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7.1
Cold pressure testing 99 Tc MIBI-SPECT useful detecting abnormal coronary
vasoreactivity in asymptomatic population with moderate risk of cardiovascular
events. PARADIGMA multicenter study.
N. Nestor Perez Balin˜o1, O. Masoli1, S. Traverso1, L. Grynberg1, C. Rappallo2, M.
Redruello2, D. Rosa2, D. Cragnolino2, A. Meretta2, L. Vidal.1 1Hospital Argerich,
Nuclear Cardiology-Div Cardiology, Buenos Aires, Argentina, 2Inst. Cardiovascular de
Buenos Aires, Nuclear Cardiology-Div Cardiology, Buenos Aires, Argentina
Correlation between Cold Pressure Testing (CPT)/ 99 Tc MIBI-SPECT defects and
intracoronary acetylcholine (ACH) paradoxical constriction was published by our group.
The usefulness of CPT non -invasive diagnosis of dysfunction (ED) was demonstrated by
our observation in coincidence with other authors. There is little information on ED
incidence on moderate risk asymptomatic (MRA) patients according to ATP III/Framing-
ham index. Objective: This study is aimed at analyzing the incidence and localization of 99
Tc MIBI/ SPECT myocardial perfusion (MP) defects during CPT as indicator of ED on
MRA patients. Methods: 124 patients (78 female) currently compounding PARADIGMA
Study Register were analyzed. PARADIGMA is a prospective multicenter study that will
include once completed a total number of 450 MRA patients according to ATP III/
Framingham index ( 20% events at 10 years ), with normal exercise MP and no
cardiovascular disease history. CPT-MP imaging was obtained in all these patients. MP
extension score was used in a 17 segment model , reported by two observers on consensus.
Mann-Whitney U Test statistical analysis was performed. l Results: positive CPT 25/113
patients (22,12 %). CPT extension perfusion score positive 5,772,38(p0.0001). CPT
was positive in 30,76 % men and 17,56 % women (p0.001). Localization : anterior wall
43 % , inferior wall 47 %, lateral wall 4,5% and anterior with inferior walls 4,5 %.
Conclusion: These results suggest high incidence of ED on MRA patients, who are also
free from exercise -- related ischemia. There were no significant differences in clinical
data and defects localization. Further studies will indicate whether this positive CPT
population would have higher risk of cardiovascular events during follow-up
Age, Bood Pressure and Cholesterol
pns (*) AGE SBP DBP CHOLEST. HDL LDL TRIGL.
CPT (  ) 55.9 10 130 12 84  5 245  90 48  19 156 49 246 143
CPT (-) 53.5  9 129  15 79 9 228  45 51  12 157  34 160 72
7.2
Effects of percutaneous intramyocardial plasmid gene transfer of vascular endo-
thelial growth factor (phVEGF-A165 ) on myocardial perfusion measured by N-13
ammonia-PET.
S. Graf1, A. Aliasghar Khorsand1, M. Gyongyosi1, G. Karanikas2, H. Eidherr2, K.
Kletter2, G. Porenta3, D. Glogar1, H. Sochor.1 1Medical University of Vienna,
Cardiology, Vienna, Austria, 2Medical University of Vienna, Nuclear Medicine,
Vienna, Austria, 3Rudolfinerhaus, Vienna, Austria
Aim: Therapeutic angiogenesis is a new therapeutic option for ischemic myocardium
without abilities of revascularisation. In a substudy of the Euroinject One randomized
double-blind trial, the effects of percutaneous intramyocardial plasmid gene transfer of
vascular endothelial growth factor (phVEGF-A165 ) on myocardial perfusion were
investigated.
Methods: Nine patients (2 females, 7 males, age 618) with severe stable ischemic
heart disease, CCS 3, and no options of conventional coronary revascularization were
randomized to receive either 0.5 mg phVEGF-A165 (VEGF; n5) or placebo (n4)
plasmid in the ischemic myocardial region, using NOGA catheter system. Myocardial
perfusion was measured by N-13 ammonia PET at rest and under pharmacologic
vasodilation with adenosine.
Results: No differences in coronary flow reserve (CFR) were found between the 2
groups at baseline. After 3 months, CFR improved insignificantly in VEGF group
(global CFR from 1,381,01 to 1,740,78; p n.s.; regional CFR in the area of VEGF
injection from 1,050,38 to 1,691,09; p n.s.), and was unchanged in Placebo group
(from 1,680,35 to 1,560,53; p  n.s.; regional CFR from 1,360,27 to 1,170,43;
p  n.s.). The difference between the groups remained insignificant.
CCS classification of angina improved significantly in both groups, but without
difference between the groups. No phVEGF-A165 -related adverse events were
observed while NOGA procedure-related adverse events occurred in 1 patient.
Conclusions: Although, no significant difference between VEGF or placebo treated
patients could be demonstrated at 3-month follow-up, a slight increase in CFR could be
observed after VEGF therapy. Transient VEGF overexpression seems to be safe.
7.3
Effects of spinal cord stimulation on myocardial perfusion and function measured
by N-13 ammonia-PET.
S. Graf1, A. Aliasghar Khorsand1, M. Beheshti2, C. Poetzi2, W. Wadsak2, K. Kletter2,
G. Porenta3, H. Sochor1, G. Maurer1, J. Wolfram.1 1Medical University of Vienna,
Cardiology, Vienna, Austria, 2Medical University of Vienna, Nuclear Medicine,
Vienna, Austria, 3Rudolfinerhaus, Vienna, Austria
Background: Spinal chord stimulation (SCS) is a new therapeutic alternative in
patients with severe coronary artery disease and no options of revascularization. SCS
has been shown to improve anginal symptoms in these patients. However, it is unknown
whether myocardial perfusion is altered by SCS.
The aim of our study was to investigate the effect of SCS on myocardial perfusion and
left ventricular function.
Methods: Twelve patients (3 females, 9 males; 665 years) with severe stable
ischemic heart disease, CCS 3, and no options of conventional coronary revasculariza-
tion were investigated. Myocardial perfusion and left ventricular function were
measured by dynamic and gated N-13 ammonia PET at rest and under pharmacologic
vasodilation (adenosine) without and with SCS therapy.
Results: No differences in coronary flow reserve (CFR) were found between the 2
investigations (1,590,54 without SCS and 1,370,3 with SCS; p  n.s.). EF was
unchanged (4712 % without SCS and 4812 % with SCS). CCS classification of
angina improved significantly under SCS therapy.
Conclusions: Significant improvement of anginal symptoms under SCS therapy may be
independent from CFR and EF that remain unaltered by SCS therapy.
7.4
Resting LVEF and transient ischemic dilatation index are predictors of all-cause
mortality in patients aged 75 years or older.
O. Olivier De Winter1, A. Velghe2, N. Van de Veire3, P. De Bondt4, M. De Buyzere3, C. Van
de Wiele4, G. De Backer3, TC. Gillebert3, RA. Dierckx4, J. De Sutter.3 1Ghent University
Hospital, Nuclear Medicine Division, Gent, Belgium, 2Ghent University Hospital, Department of
Geriatrics, Ghent, Belgium, 3Ghent University Hospital, Cardiology Department, Ghent, Belgium,
4Ghent University Hospital, Nuclear Medicine Division, Ghent, Belgium
Aim: Perfusion and functional gated SPECT data have prognostic value in the middle-aged
patient population. Our aim was to investigate if these data have incremental value above
clinical parameters in patients aged 75 years or older.
Methods: All patients underwent a 2 day stress-rest tetrofosmin gated SPECT study. Resting and post
stress left ventricular (LV) ejection fraction (EF) and volumes and transient ischemic dilatation ratio
(TID) were calculated using QGS software. Univariate predictors of were investigated using Mann
Whitney U testing. Significant univariate predictors were inserted in a stepwise multivariate Cox
proportional hazard model to determine independent predictors of mortality.
Results: The population consisted of 294 patients (54% males, median age 78). There were 47 (16%) patients
who died during a median follow-up of 25.9 months. A higher resting heart rate and the absence of beta-blocker
treatment were independent clinical predictors of mortality (Chi-square 13.8; p.001). Although all LV
functional variables (EF and volumes) and the defect extent on stress and rest imaging were univariate predictors
of mortality, only a lower resting LVEF (Chi-square gain of 14.9, p.001) and a higher TID (Chi-square gain
of 6.3, p.015) provided independent prognostic value above the clinical model. The figure shows the
Kaplan-Meier survival curve in patients with a resting LVEF over 45%, between 45 and 30% and below 30%.
Conclusions: Resting LVEF and TID ratio determined by gated SPECT are important
predictors of all-cause mortality and have incremental prognostic value in patients aged 75
years or older referred for myocardial SPECT imaging.
Kapl-Meier curve
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7.5
Post stress endsystolic volume and kidney function are independent determinants of
NTproBNP levels in elderly patients with coronary artery disease.
O. Olivier De Winter1, N. Van de Veire2, M. De Buyzere2, TC. Gillebert2, D. Bernard3, M. Langlois3, RA.
Dierckx4, J. De Sutter.2 1Ghent University Hospital, Nuclear Medicine Division, Gent, Belgium,
2Ghent University Hospital, Cardiology Department, Ghent, Belgium, 3AZ Sint-Jan, Depart-
ment of Biochemistry, Brugge, Belgium, 4Ghent University Hospital, Nuclear Medicine
Division, Ghent, Belgium
Aim: N-terminal proBNP peptide (NTproBNP) is a valuable tool in the diagnosis of heart failure and has
a prognostic value in CAD patients (pts). Parameters derived from gated SPECT and kidney function
have however also a strong prognostic value in these pts. Our study aim was to assess whether gated
SPECT data and kidney function are independent determinants of NTproBNP in CAD pts above 65
years.
Methods: We studied 131 consecutive pts with stable CAD referred for myocardial perfusion imaging.
Left ventricular (LV) volumes were derived from myocardial gated SPECT data. Summed stress, rest
and difference scores were calculated using semi-quantitative 4DM SPECT software (Michigan U.).
Glomerular filtration rate (GFR) was calculated with a validated equation based on serum creatinine
level.Univariate clinical and SPECT determinants of NTproBNP were investigated using ANOVA. A
linear regression model was used to determine independent predictors of log NTproBNP.
Results: The study population consisted of 131 pts (79 males, mean age 716 y). Univariate predictors
of a higher NTproBNP were a lower GFR (p.001), a longer QRS duration (p .008), higher resting
& post-stress end-diastolic and end-systolic (ESV) volumes (all p.001)and a a higher summed stress
and rest score (both p .001). GFR (F change 44.4; p .001) and post stress LV ESV (F change
31.5; p.001) were the only independent determinants of log NTproBNP in the regression analysis. In
the figure mean log NTproBNP values in these pts are shown according to a low versus high GFR
(divided on the median) and post stress LVESV (divided in tertiles).
Conclusion: Post stress LV ESV and kidney function (assessed by GFR) are the main
independent determinants of NTproBNP in CAD pts aged 65 years or older.
Figure
7.6
The use of logistic regression analysis based on clinical epidemiological data and
treadmill test results to select patients to undergo myocardial perfusion scintigra-
phy.
P.S. Paulo Duarte1, L.E. Mastrocolla1, C.R.E. Sampaio1, J.M. Rossi1, P.E. Smanio1,
E.V. Lima1, C.A.R. Oliveira1, J.C.R. Pereira.2 1Fleury-Centro de Medicina Diagno´stic,
Nuclear Medicine, Sa˜o Paulo, Brazil, 2Health Public School-USP, Epidemiology, Sa˜o
Paulo, Brazil
Background: early detection of coronary atherosclerotic disease (CAD) is important to
prevent death and disability. Myocardial perfusion scintigraphy (MPS) has the appro-
priate diagnostic and prognostic applications for patients who have an intermediate or
high likelihood of disease, but it may not be cost-effective and should be performed
only when reasonable doubt is left from other less sophisticated approaches. Based on
clinical-epidemiological (CE) probability algorithms of CAD, patients classified as low
likelihood of disease might either have no testing or simply undergo exercise testing
(EXT). If the EXT results negative the patient is simply followed up; if the EXT is
positive, the nuclear test is appropriate. Although this information is useful, it has some
problems when in clinical practice. The challenges are how to adequately define patients
in terms of likelihood of disease and how to integrate the pre-test probability with EXT
results. Objective: to create and evaluate a logistic regression equation to classify
patients to be referred to MPS based on the analysis of CE and EXT data. Methods: CE
and EXT data on 2099 patients who had MPS performed in a nuclear medicine
laboratory from 06/2000 to 06/2003 were collected for analysis. None of these patients
had previous history of CAD. Each one was classified by utilizing a modified CE score
based on the Framingham study database and EXT information derived from Duke
Score (DS). The patients with abnormal results on MPS were followed for a mean
period of 16 months. Comparing CE and EXT results with information on the presence
of cardiac event in the patients’ follow-up, a logistic regression equation was calculated
to estimate the probability of truly abnormal results on MPS. 1052 patients randomly
selected were utilized to create the logistic regression equation and 1047 to test the
results. It was utilized the ROC curve to check the sensitivity and the specificity of the
equation. Results: the logistic regression equation was y -5.19 0.17CE-0.16DS, the
ROC curve area was 0.94 (95% CI: 0.92-0.98) and specificity as high as 82% was
achieved keeping the sensitivity high (100%). Conclusion: a model based on logistic
regression analysis demonstrated to be accurate in the classification of the patients that
should undergo MPS, and has the potential to save financial resources, precluding
patients with low probability to have truly abnormal result on MPS to perform this test.
7.7
Cardiac events after five years of a normal perfusion myocardial scintigraphy.
P. Paola Smanio1, P. Beraldo2, F. Rodrigues3, A. Thom.3 1Instituto Dante Pazzanese,
Cardiologia nuclear, Sa˜o Paulo, Brazil, 2Instituto Dante Pazzanese, Coronary, Sa˜o
Paulo, Brazil, 3Instituto Dante Pazzanese, Nuclear Cardiology, Sa˜o Paulo, Brazil
Studies have already been published, showing a lower risk of cardiovascular events
after one year of a normal myocardial perfusion scintigraphy (MPS) in population with
and without known significant coronary artery disease (CAD).
The aim of this study is to evaluate the follow up after five years of a normal MPS in
a high risk of CAD patients (p) with and without known CAD.
Methods: Were analyzed 2.500 p that performed MPS on 1998. Were selected 300 p
with normal MPS. Patients were divided in two groups: A group: 140 p with known
CAD; and B group: 160p without known CAD. All p have at least 3 risk factors for
develop CAD (Hypertension, diabetes, tabagism, high cholesterol blood levels, obesity
and familiar history of CAD) . All studies were performed with sestamibi-Tc-99m by
tomographic technique (SPECT). From the total, 120 p had performed exercise and 180
pharmacological stresses with dipyridamole. As hard event were considered cardiac
death and myocardial infarction (MI) and as soft cardiac events were considered cardiac
bypass surgery (CABG), angioplasty/Stent implantation and cardiac catheterization
(CATH) at the 5 year follow up. Were considered as normal MPS when there were no
perfusion defects after the stress imaging.
Results: Verify at the Table bellow. There was no significant difference (p0,10)
between the 2 groups in despite of hard events. In both groups there were a small
number of hard events in five years (10/3003%). In considering soft events, were
observed at A group: 35/14025% and at B group: 16/16010%.
Conclusion: The results may suggest that even after 5 years, patients with a normal
MPS have a low prevalence of hard events. In despite of soft events, the prevalence was
higher in patients with known CAD.
Cardiac Events
Death MI CABG ATC/STENT CATH
A group 3(2%) 3(2%) 2(1,4%) 8(5,7%) 25(17,8%)*
B group 2(1,2%) 2(1,2%) 5(3,1%) 5(3,1%) 6(3,7%)
Death: cardiac death; MI:myocardial infarction; CABG: bypass surgery; ATC/STENT:
angioplasty/Stent implantation; CATH: coronary angiography;* p  0.05
7.8
Myocardial efficiency reserve predicts the deterioration in exercise capacity over
time in patients with heart failure.
K. Keiichiro Yoshinaga, H. Ukkonen, I. Burwash, R. DeKemp, W. Dafoe, R. Davies,
H. Haddad, T. Ruddy, J. DaSilva, R. Beanlands. University of Ottawa Heart Institute,
Cardiac PET Centre, Ottawa, Canada
Backgrounds: Myocardial efficiency (ME) and ME reserve (MER) can be estimated
non-invasively using C-11 acetate PET measurement of oxidative metabolism and
echocardiographic measurement of stroke volume (SV) at rest and during dobutamine
infusion. In patients with heart failure (HF), ME has been shown to be a predictor of
survival. However, the potential utility of ME or MER for predicting the functional
capacity of HF patients in follow-up has not been defined. We investigated whether ME
and MER could provide prognostic information on the exercise (Ex) capacity of HF
patients over time. Methods: 25 patients with HF were prospectively studied
[age668 yrs, LVEF318%, ischemic (n18)]. ME was estimated by the
Work-Metabolic Index (WMI  SV index (SVI)  HR  systolic BP/ k-mono, where
k-mono is the monoexponential fit of the myocardial C-11 acetate PET time-activity
curve). MER was derived from the % change of WMI between rest and during
dobutamine infusion (10 	g/kg/min). Ex capacity [maximal oxygen uptake (Peak
VO2)] was measured at baseline and at 6 months follow-up in all patients. Worsening
Ex capacity was defined as  10% decrease in peak VO2. Results: At the baseline
study, dobutamine infusion resulted in an increase in SVI (359 to 409 ml/m2,
p0.001), k-mono (0.0470.009 to 0.0610.013/min, p0.001) and WMI
(6.11.710000 to 7.91.810000, p0.001). MER was 3226%. From baseline to
6-month follow-up, Ex workload and peak VO2 decreased from 4.81.4 to
4.31.1METS (p0.03), and 16.74.8 to 15.23.8 ml/kg/min (p0.057), respec-
tively. Among rest and dobutamine parameters, only MER correlated with the change
in Ex capacity over time (r0.56, p0.005). An MER  35% predicted a worsening
exercise capacity with a sensitivity, specificity, PPV and NPV of 79%, 82%, 85%, and
75%, respectively. Conclusions: Myocardial efficiency reserve correlates with the
change in exercise capacity over time in patients with HF. A myocardial efficiency
reserve  35% predicts functional deterioration with good accuracy. The myocardial
efficiency reserve may be a useful clinical prognostic parameter in heart failure patients.
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7.9
Prognostic value of rubidium-82 perfusion positron emission tomography in
patients referred after SPECT imaging.
K. Keiichiro Yoshinaga, B. Chow, R. DeKemp, K. Williams, L. Garrard, A. Szeto, M.
Aung, R. Davies, T. Ruddy, R. Beanlands. University of Ottawa Heart Institute, Cardiac
PET Centre, Ottawa, Canada
Background: Previous studies have suggested that positron emission tomography
(PET) myocardial perfusion imaging has superior accuracy than SPECT for the
diagnosis of coronary artery disease. However, its role in clinical practice continues to
be evaluated. The purpose of this study was to determine the prognostic value of
Rubidium-82 PET for prediction of cardiac events (cardiac death, myocardial infarction,
revascularization, and cardiac hospitalization) in patients who were referred for PET
imaging after perfusion SPECT imaging.
Methods: We studied 393 consecutive patients who underwent dipyridamole stress/rest
Rubidium-82 PET and were followed for 3.21.2 years. 92 patients of these had been
referred after a Tc-99m perfusion SPECT study. PET imaging was visually assessed
using a 17 segment model scored on a 5 point scale (0normal, 4absent uptake).
Summed stress score (SSS), summed rest score (SRS), and summed difference score
(SDSSSS-SRS) were calculated. SSS and SRS were divided into 4 groups (
4normal; 4 to 7mild, 8 to 11moderate, and  11severely abnormal). SDS  2
was considered a reversible defect abnormality.
Results: Among the 92 recent SPECT studies, 12 had been reported as normal, 75 had
reported attenuation artifacts and 5 cases were abnormal. All 5 abnormal SPECT studies
were abnormal on PET and were not included in this outcome analysis. Among the
remaining 87 patients with normal or possible attenuation SPECT studies, PET was
abnormal in 12 and normal in 75 cases. During the follow-up period for these 87
patients, 13 cardiac events occurred: 1 myocardial infarction, 5 late revascularization (
3 months) and 7 hospitalizations due to angina. Patients with normal PET scans had a
94.7% (71/75) event-free survival (mean follow-up: 3.2 yrs) (1.65%/year event rate),
compared with 25% (3/12) event-free survival in patients with abnormal PET scans
(23.4%/year event rate) (chi-square, p  0.01).
Conclusion: Rubidium-82 perfusion PET has prognostic value in patients with
coronary artery disease referred after SPECT imaging. In patients in where diagnostic
results are uncertain after SPECT imaging, Rubidium-82 PET provides excellent
clinical utility.
7.10
Impact of type 2 diabetes on myocardial perfusion and glucose uptake in areas
supplied by stenotic and non-stenotic coronary arteries.
H. Hanne Sondergaard1, M. Bottcher1, MM. Madsen1, O. Schmitz2, TT. Nielsen1, HE.
Botker.1 1Aarhus University Hospital, Skejby, Department of Cardiology, Aarhus N,
Denmark, 2Aarhus University, Department of Clinical Pharmachology, Aarhus, Den-
mark
Background: Type 2 diabetes (T2DM) is recognized as a state of whole-body insulin
resistance (IR). Myocardial IR appears to be present in T2DM with coronary artery
disease (CAD), but not in T2DM patients without concomitant CAD. However, it is not
clear whether myocardial IR is present in areas supplied by a stenotic or a non-stenotic
coronary artery.
The aim of the study was to compare basal and insulin stimulated myocardial perfusion
and glucose uptake in areas supplied by a stenotic (S) and a non-stenotic (NonS)
coronary artery in CAD patients with or without T2DM, and in healthy controls.
Method: We studied 9 patients with T2DM and angiographically verified CAD (618
years), 9 patients without T2DM but with CAD, and 8 matched controls without T2DM
or CAD (566 years). Patients had one area supplied by a stenotic artery, at least one
area supplied by a non-stenotic artery and preserved left ventricular function. Myocar-
dial perfusion and MGU were measured with PET using 13N-ammonia as perfusion
tracer and 18F-fluoro-deoxy-glucose as glucose tracer. Perfusion was measured at rest
and during dipyridamole vasodilation with and without hyperinsulinemic euglycemic
clamp (1mU/kg/min).
Results: Whole body glucose uptake was similar in T2DM and CAD but increased in
controls (4.112.8 and 5.453.0 vs. 6.92.3 mg/kg/min, P0.05). Myocardial
glucose uptake was similar in NonS and S areas in both T2DM and CAD (0.420.11,
0.390.11, 0.330.08 and 0.370.09 	mol/g/min, P0.4). These values did not differ
from controls (0.340.08 	mol/g/min, P0.1).Myocardial perfusion at rest was similar
in NonS and S areas in T2DM and CAD (0.90.3, 0.80.2, 0.90.3 and 0.80.1
ml/g/min, P0.7). Dipyridamole increased perfusion similarly in T2DM and CAD, but
flow reserve was reduced in S areas in T2DM as well as CAD. Insulin did not alter
perfusion at rest or after dipyridamole infusion.
Conclusion: Myocardial insulin resistance is not an inherent feature of T2DM
irrespective of the degree of epicardial disease and whole-body IR. CAD is also
associated with whole body IR, but IR does not affect the myocardium when
contractility is preserved.
7.11
Clinical classification of stable angina pectoris patients is not reliable-not even in
high risk patients.
P.F. Poul.F. Høilund-Carlsen1, A. Johansen1, H.W. Christensen2, W. Vach3, M.
Møldrup1, T. Haghfelt.4 1Odense University Hospital, Nuclear Medicine, Odense C,
Denmark, 2Nordic Institute, Chiropractic and Clinical Biomechanic, Odense, Denmark,
3University of Southern Denmark, Statistics, Odense, Denmark, 4Odense University
Hospital, Cardiology Dept., Odense, Denmark
According to ACC/AHA guidelines patients with chronic stable angina based on history,
clinical judgment and estimation of pretest likelihood of coronary artery disease (CAD)
should be referred directly to catherization and eventually invasive revascularization.
However, in patients with a normal myocardial perfusion imaging (MPI) scan, invasive
procedures mean a stepping up in risk, especially in elderly and high risk patients.
Aim: To compare clinical classification and pretest probability estimates in these
patients with the outcome of MPI and coronary angiography (CA), 50% diameter
stenosis indicating significant CAD.
Methods: 476 patients (aged 57.7  9.1 years) referred to CA for known or suspected
stable angina estimated their degree of chest pain (0no pain; 10worst pain) on a
visual analog scale (VAS) before a single physician judged their type (typical angina,
atypical angina, non-cardiac or no chest pain) and Canadian Cardiovascular Society
(CCS) grade (0-4) of chest pain. Pretest likelihood of CAD was estimated based on type
of chest pain, age, and gender. All patients underwent MPI followed by CA in mean two
months later. Blinded design was used throughout.
Results: The table displays data from the approximate “upper half” of the patients, i.e.,
patients with expectedly more severe disease. It appears that 37%-46% of this category
of patients had a normal MPI, and that 35%-53% had insignificant CAD. About 25% of
patients with a pretest likelihood of CAD 94% had a normal MPI.
Conclusion: In patients referred to CA for known or suspected stable angina, clinical
classification and a simple system for the prediction of CAD is unreliable with regard
to myocardial perfusion status and the presence of significant angiographic disease.
Table 1
MPI MPI MPI MPI CA CA CA CA
Normal Reversible Mixed Fixed O VD 1 VD 2 VD 3 VD
VAS score 3(n254) 46% 25% 17% 12% 53% 17% 13% 17%
Typical angina (n279) 41% 31% 17% 11% 41% 20% 19% 20%
CCS grade 1 (n272) 38% 31% 20% 11% 41% 21% 17% 21%
High pretest likelyhood (n224) 37% 34% 19% 10% 35% 19% 22% 24%
Clinical classes vs results of MPI and CA (VD  vessel disease)
7.12
Relationship between symptoms and perfusion status before and after revascularization
in patient with stable angina pectoris.
A. Allan Johansen1, PF. Høilund-Carlsen2, HW. Christensen3, W. Vach4, M. Møldrup2, T.
Haghfelt.5 1Odense University Hospital, Department of Nuclear Medicine, Odense C, Denmark,
2Odense University Hospital, Nuclear Medicine Dept., Odense, Denmark, 3Nordic Institute, Chiropractic
and Clinical Biomechanics, Odense, Denmark, 4University of Southern Denmark, Statistics Dept.,
Odense, Denmark, 5Odense University Hospital, Department of Cardiology, Odense C, Denmark
Aim: We wanted to examine the relationship between symptoms and perfusion before and after
revascularization in patients with stable angina.
Methods: 380 patients (147 females), aged 58.0 8.8 years, referred to coronary angiography due to
known or suspected stable angina were classified as suffering from typical/atypical angina or non-cardiac
chest pain/no pain. Myocardial perfusion imaging (MPI) using a dual isotope (exercise/pharmacological
169/211) protocol was performed. The choice of management (revascularization or medicine only) was
based on history and angiographic findings since the MPI results were not communicated. Follow-up,
including repeat MPI, was completed after 2-years.
Results: 144 (38%) patients were revascularized. Initially, 320 (84%) had typical/atypical angina and 60
(16%) non-cardiac chest pain/no pain. At follow-up, 145 (38%) had typical/atypical angina, while 235
(62%) had non-cardiac chest pain/no pain. However, when separated according to treatment, a significant
difference could be demonstrated in revascularized patients only. Sum stress score (SSS) was
significantly reduced in revascularized patients, and not significantly changed in non-revascularized
patients. The relationship between type of chest pain and perfusion status in revascularized patients is
shown in Figure 1. Among patients with initially typical or atypical angina (designated typ), it was only
those who had non-cardial chest pain or no pain at follow-up (designated ncp) who had a significant
reduction in SSS. In non-revascularized patients, there were no significant changes.
Conclusion: A relationship between perfusion and angina type was documented in that relief of typical
or atypical angina was associated with improvement of perfusion.
Figure 1
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7.13
Metabolic support with glutamine or glutamate was not cardioprotective in a
porcine model assessed by MPI.
J. Jens Hedega Kristensen1, M. Maeng2, UM. Mortensen2, JS. Berg2, M. Rehling1, TT.
Nielsen.2 1Skejby University Hospital, Nuclear Medicine, Aarhus., Denmark, 2Dept. of
Cardiology, Aarhus, Denmark
Objective: Previous experimental studies indicate that glutamine or glutamate may be
cardioprotective by improving oxidative metabolism in myocardial ischemia. We
investigated the effect of glutamine or glutamate, given during reperfusion on resulting
infarct size, assessed by m99Tc-sestamibi MPI.
Design: A porcine coronary occlusion model was applied. Infusions were initiated 15
min before reperfusion, and supplemented with intracoronary bolus infusions at
reperfusion. Primary outcome measures were infarct size (IS) in relation to area at risk
(AAR), assessed by myocardial perfusion imaging with m99Tc-sestamibi (MPI) and a
standard tissue staining procedure for comparison.
Results: Determined by histochemistry the IS/AAR (mean SD) were: Control group:
0,64  0,19 (n9), Glutamine group: 0,87  0,07 (p 0,05 vs. control group) (n8),
Glutamate group: 0,72  0,11(n9). Corresponding values determined by MPI were:
Control: 0,87  0,3, Glutamine group: 0,97  0,04, and for glutamate group: 0,85 
0,13. Glutamine increased systemic vascular resistance, while glutamate preserved
cardiac output during infusion.
Conclusion: Substrate supplementation with the anaplerotic precursors glutamine and
glutamate are ineffective as adjunctive therapy for severe myocardial ischemia.
Beneficial effects documented in less complex experimental systems could not be
transferred to a more pathophysiological relevant model. In vivo MPI is almost as
precise in assessing the IS/AAR compared to ex vivo histochemistry, also reflecting
smaller differences in IS.
7.14
Relation of stress myocardial perfusion defects and left ventricular function
parameters as assessed by gated single photon emission tomography using
99mTC-sestamibi.
K. Khaled Elsaban1, T. El-Kady2, M. El-Gabaly2, A. Yehia2, M. El-Sayed.3 1Faculty of
Medicine, Cairo University, Nuclear Medicine, Cairo, Egypt, 2National Heart Institute,
Nuclear Cariology, Cairo, Egypt, 3Assuit University, Nuclear Medicine, Assuit, Egypt
Background: Infarct size (and severity) and LVEF (and volumes) derived from a gated
SPECT study correlate closely. However, till our knowledge there is no detailed
information about the recent summed score and left ventricular function and to which
extent it affects EF.
Aim of the Study: to identify the correlation between the size of myocardial perfusion
defect during exercise and both ejection fraction and LV wall motion abnormalities
obtained by gated SPECT (gSPECT) and to determine threshold level of SSS
contributing to reduction of EF below 40%.
Patients and Methods: 30 patients with known coronary artery disease had been
subjected to exercise 99mTc-MIBI gSPECT and resting echocardiography. Myocardial
perfusion and resting echocardiography had been divided into 17 segments with scoring
of myocardial perfusion using 0-4 score and summing the score at stress (summed stress
score SSS), rest (summed rest score SRS) and getting the difference (summed
difference score SDS). Wall motion assessment had been done in both resting
echocardiography and gSPECT using 1-4 score.
Results: SSS had been found to had modest inverse correlation with EF detected
angiographically (r-05981), echocardiographically (r-0.5504), and by gSPECT at
rest (r-0.5242) and stress (r-0.6398). In addition, patients with EF 40% (7
patients) had higher SSS than patients with EF40%. Accordingly, receiver operating
curve (ROC) could separate these two groups by SSS  10. Concerning wall motion
abnormality(WMA), perfusion status showed similar affection of WMA by both echo
and gSPECT, with modest correlation between SSS and wall motion score measured by
either techniques and higher tendency for gSPECT.
Conclusion: Using gSPECT is very informative in patients with CAD. SSS is
correlated with EF with the ability of detection of patients with lower EF using SSS
10.
7.15
Motion detection and correction for dynamic cardiac PET water studies.
A. Alexandru Naum, M.S. Laaksonen, H. Tuunanen, V. Oikonen, J. Kemppainen, M.J.
Ja¨rvisalo, P. Nuutila, J. Knuuti. Turku University, Turku PET Centre, Turku, Finland
Background: Patient motion during dynamic PET studies is a well documented source
of errors. Frame to frame misalignment will modify the measured time activity curve
from a selected region of interest (ROI) which can affect results.
We have developed a motion detection algorithm and examined two registration
methods for dynamic cardiac PET water studies, based on alignment of each PET frame
with a reference image.
Methods: Normal volunteers underwent a 15O-water PET flow study at rest, during
adenosine infusion and bicycle exercise in the same session. Before PET acquisition two
external radioactive skin markers (22Na) were placed on the back of the patient at the level
of thoracic vertebra T7. Space coordinates on X, Y, Z-axis inside the FOV has been
determined, and the corresponding (pixels) distance from the origin of FOV was recorded
in each frame.
The highest number of frames having identical markers spatial coordinates reported to
origin of FOV during the study were defined as non moved.
A reference image obtained by summing all non-moved frames was used for further
alignment. Registration was performed manually and automatically by applying a least
squares registration algorithm. Values of myocardial blood flow were calculated using a
single tissue compartment model.
Results: In original datasets at rest motion was detected in 4 2 frames, out of 20 analyzed.
The corresponding values during adenosine and exercise were 9  3 and 16  2.
Compared to original datasets in manually corrected data, motions was encountered at
rest in 2  1, during adenosine, 3  4, and exercise 5  4 frames.
Least squares corrected motion studies presented motion at rest in 1  1 frames, during
adenosine and bicycle exercise 2  3 and 1  2.
MBF quantitated values in non corrected datasets were at rest 0.77 0.18 ml/g/min, during
adenosine and exercise 2.83  1.17 ml/g/min respectively 1.38  0.39 ml/g/min.
Values after manual and least squares motion correction were at rest 0.74  0.13
ml/g/min, p  0.74, ns and 0.82  0.4 ml/g/min, p  0.62 ns, during adenosine 4.03 
3.01 ml/g/min, p  0.23, ns and 4.05  2.93 ml/g/min, p  0.24, ns.
MBF measured values in corrected studies during dynamic exercise were 1.9  0.33
ml/g/min, p  0.003 (manually corrected) and 2  0.55 ml/g/min, p  0.019 (least
squares corrected).
Conclusions: The proposed frames realignment methods seems to be feasible in our
study, reducing the number of moved frames and provided higher values of myocardial
blood flow, during adenosine and dynamic exercise, compared with those without
motion correction.
7.16
Correlation between N-Terminal pro-brain natriuretic peptide and myocardial
perfusion defects in patients with stable coronary artery disease and normal
ejection fraction.
G. Gerald Vanzetto1, P. Jacon1, D. Fagret2, J. Machecourt.1 1Chu de Grenoble, Cardiologie,
Grenoble, France, 2University Hospital, Nulear Medicine, Grenoble, France
BACKGROUND: The prognostic value of NT-pro-brain natriuretic peptide (NT-proBNP) has
been demonstrated in patients with acute coronary syndromes but not in patients with stable
coronary artery disease (SCAD). We aimed to determine the relationship between NT-proBNP
values and the extent of myocardial perfusion defects on exercise (EST) Tl201 SPECT in SCAD
pts with normal ejection fraction (EF  45%).
METHODS: 88 patients (79 men, mean age 618 years) with documented CAD and
without history or symptoms of congestive heart failure were included. 53 patients
(60%) had a history of previous myocardial infarction  3 months. Mean EF was
6211%. NT-proBNP was measured at baseline, peak-EST, and 3 hours after EST
(Post-EST).
RESULTS: SPECT was normal in 33 patients (37%, group 1) and abnormal in 55
(63%, group 2-fixed defects n33, reversible defects n49). EST data were similar in
both groups. We observed a significant but weak correlation between Post-EST
NT-proBNP values and the extent of perfusion abnormalities (r0.49, p0.001).
However, Group 2 patients had higher baseline, peak-EST and post-EST NT-proBNP
values than group 1 (Table below). NT-proBNP baseline vs. post-EST variations were
also higher in group 2. Post-EST NT-proBNP was predictive of perfusion abnormalities
and of moderate-to-severe ischemia (areas under the ROC curves  0.71 and 0.61
respectively). A post-EST NT-proBNP value  190 pmol/ml ruled-out moderate-to-
severe myocardial ischemia with a negative predictive value of 85%. The accuracy of
combined EST and post-stress NT-proBNP was 74% for identifying the presence or
absence of significant ischemia.
CONCLUSION: A single post-EST NT-proBNP measure accurately predicts the presence or
absence of significant myocardial ischemia in SCAD and can be useful for selecting patients
requiring perfusion imaging as second line diagnostic or prognostic tool.
NTBNP values
Group 1 Group 2
Baseline 107 (52-172) 183 (100-274)*
Peak-Est 119(56-182) 201(110-311)*
Post-EST 122(59-195) 213(108-326)*
Baseline-Post EST 16 (6-25) 23 (7-66)*
Value are medians (interquartile range). *p  0.05 versus Group 1
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7.17
The effects of mid-term cardiac resynchronisation therapy on myocardial perfu-
sion at rest and after vasodilation and on myocardial oxygen consumption in heart
failure patients.
O. Oliver Lindner1, J. Vogt2, A. Kammeier1, E. Fricke1, P. Wielepp1, D. Baller2, B.
Lamp2, J. Holzinger2, D. Horstkotte2, W. Burchert.2 1Heart and Diabetescenter NRW,
Nuclear Medicine, Bad Oeynhausen, Germany, 2Heart and Diabetescenter NRW,
Department of Cardiology, Bad Oeynhausen, Germany
Cardiac resynchronisation therapy (CRT) has shown to improve hemodynamics and
clinical symptoms in heart failure patients with broad QRS complex and left bundle
branch block (LBBB) morphology. The present study evaluated the effects of mid-term
CRT on myocardial blood flow (MBF) at rest, after dipyridamole induced vasodilation,
and on myocardial oxygen consumption (MVO2) at rest.
Methods: 16 NYHA III patients (age 655 y) with idiopathic dilated cardiomyopathy
(ejection fraction 22.67.6%) and LBBB (QRS width 187.217.5 ms) were studied
prior to and after 15 weeks of continuous CRT. The pacemaker was adjusted to its
optimal AV-delay and to its optimal pacing site. All patients had a positive acute
response (pulse pressure increase  10 %) to a biventricular pacemaker system in a
electrophysiologic pretest. Resting MVO2 and MBF of the global myocardium and of
the anterior, lateral, inferior, and septal wall were determined from an 11C-acetate PET
study and vasodilator MBF after dipyridamole infusion from a 13N-ammonia study.
Results: global MBF at rest, after vasodilation, MBF reserve, and resting MVO2 were
found to be below the normal limit at baseline did not change by mid-term CRT,
whereas the rate pressure product (RPP) normalized MVO2 decreased (P0.018). At
baseline, the regional analysis revealed significantly higher values of all parameters in
the lateral wall than in the other myocardial walls. Under CRT, the regional differences
of the resting parameters equalized. All parameters showed a significantly smaller
coefficient of variation among the myocardial walls. The hemodynamic data revealed a
higher systolic blood pressure (P0.009). Diastolic blood pressure, heart rate and the
RPP remained unchanged.
Conclusion: effects of mid-term CRT on MBF at rest, after pharmacological vasodi-
lation and on MVO2 occur on a regional level. The intraventricular resynchronization
is associated with a smaller regional variability of MBF and MVO2 between the
myocardial walls. Considering MVO2 and the RPP, there is evidence of an improved
ventricular efficiency. Substantial alterations of global MBF at rest, MBF after
vasodilation, or MVO2 by CRT are not detectable. This indicates no substantial
improvement of the underlying cardiomyopathy within the observation period.
7.18
Integration of function and morphology in cardiac PET/CT: a feasibility study in
patients with chronic and ischemic heart disease.
S.G. Stephan Nekolla1, M. Souvatzoglou1, J. Hausleiter2, N. Henke1, K. Kruschke1, F.
Bengel1, M. Schwaiger.1 1Technische Universita¨t Mu¨nchen, Nuklearmedizinische
Klinik, Mu¨nchen, Germany, 2Deutsches Herzzentrum Bayern, Munich, Germany
Aim: The key strength of PET is high physiological contrast; however, spatial
resolution is only modest. With the success of PET/CT imaging devices in oncology
(especially with high quality 16 detector CT systems integrated), this offers excellent
means towards an “one-stop-shop” in cardiac imaging. For this purpose, we imple-
mented an integrated approach from acquisition protocols to analysis modules and
evaluated their feasibility in viability and ischemia imaging.
Methods: Using a combined PET/CT tomograph (Siemens Biograph 16, LSO detec-
tors), a study population of 10 patients (6212y, 8 m) with severe 3 vessel disease of
the left ventricle (LV) (group V) and 10 patients (5914y, 9 m ) with previous
myocardial infarction (group I) was examined. The imaging protocol consisted of an
initial low dose CT for attenuation correction and list mode PET imaging after the
injection of 300-450 MBq N-13 ammonia for 10 min. In group V, this was followed by
30 min list mode F-18 FDG imaging (300 MBq); in group I the NH3 protocol was
repeated under adenosine stress. ECG traces were recorded throughout the measure-
ments. All PET imaging was done in 3D mode and images were reconstructed using an
OSEM algorithm. Finally, CT calcium scoring (group I only) and CT angiography
(CTA) was performed using an iodine based contrast agent after identifying the optimal
injection delay with a test bolus. Regional uptake of NH3 and FDG (group V) as well
as regional parameters (myocardial blood flow, flow reserve (only group I), metabolic
rate of glucose utilization) were quantified. From the CT data, regional calcifications,
wall motion and thickness were delineated. In addition, the coronary tree was
visualized.
Results: The protocols took an average of 60 min (group I) and 90 min (group V) to
acquire. List mode histogramming and reconstruction required 30-40 min and was
followed by 30 min of image analysis. Consequent patient monitoring was found to be
mandatory to limit motion resulting in misalignment of emission and morphological
information. Although the heart rate in group V was significantly higher and ejection
fraction reduced (7512BPM vs. 559BPM and 326% vs. 4412%), wall thickness
and wall motion was assessable by CTA in all cases.
Conclusions: Characterization of myocardial tissue based on functional and morpho-
logical means is realized within one imaging examination. However, the high com-
plexity of data acquisition, reconstruction and analysis warrants its validation in a larger
patient population also taking cost effectiveness and radiation exposure into account.
7.19
Role of myocardial perfusion imaging in evaluation of patients with non transmu-
ral myocardial infarction.
P.S. Palaniswamy Shanmuga Sundaram1, S. Padma1, K.K. Haridas2, S. Kumar1, M.
Zachariah.1 1Amrita Institute of medical sciences, Nuclear Medicine, Cochin, India,
2Amrita Institute of Medical Sciences, Adult Cardiology, Cochin, India
Non Transmural Myocardial Infarction (NTMI), also known as Non Q wave Myocar-
dial Infarction (NQMI) was previously dealt as “mild” coronary events due to modest
cardiac enzyme level elevations. Substantial evidence now calls for modifying this
approach because if diagnosed early & intervened, results in a favorable long-term
prognosis. Risk stratification of NTMI pts with Myocardial Perfusion Imaging (MPI) is
essential to avoid late complications like recurrent angina, Transmural Myocardial
Infarction (TMI) & sudden death.We hypothesized that NTMI might have more residual
ischaemia or hibernating myocardium than TMI.
METHOD: 120 pts (M : F  88 : 32, age range 47  9 yrs) proven / suspected to have
MI undergoing MPI for risk stratification between Jan-02 to Sep-02 were analyzed. Pts
with previous revascularisation, normal MPI findings were excluded. Pts underwent
same day 99mTc SestaMIBI rest-stress gated SPECT. All pts had resting 12 lead ECG
& pts with pathological Q waves (width  0.04 sec & depth  1/4 R wave) in 2
consecutive ECG leads were classified as TMI. Presence of myocardial scar in at least
2 adjacent segments in MPI without Q wave on ECG was considered to be NTMI. A
perfusion defect was defined as  50 % MIBI uptake & a reversible perfusion defect
was defined as improvement in tracer uptake from stress to rest images at least by 10%
or more. Hibernation was termed when a segment with near normal uptake showing
good wall thickening but significant hypokinesia on gated study. ECG analysis was
blinded to SPECT study.
RESULT: Results were interpreted visually & with a 20-segment myocardial model. 78
(65%) pts had TMI & 42 (35%) had NTMI.Images were evaluated for presence of stress
induced LV dilatation, reversible perfusion defects & wall thickening/motion in gated
images. NTMI category pts had a higher incidence of reversible ischemia, hibernation
(26/42pts-62%) than in TMI (23/78 pts-30%). Mean segments of viable myocardium
(ischaemia  hibernation) in NTMI were significantly more than those in TMI (5.1-3.7
Vs 3.0-2.9 p 0.05). In NTMI pts of our series,LAD territory segments were more
frequently involved than others(5/26-58%).
CONCLUSION:
Extent & incidence of reversible ischemia & myocardial hibernation is significantly
more with NTMI than TMI. So it is important to risk stratify NTMI pts with myocardial
perfusion SPECT enabling aggressive approach to salvage myocardium at risk.
7.20
Clinical predictors and prognostic value of stress induced abnormal Tl-201
myocardial perfusion SPECT in asymptomatic patients with diabetes mellitus.
S. Shay Livschitz1, T. Zornitzki1, S. Vered2, M. Oettinger1, R. Levy1, A. Caspi1, D.
Faraggi2, H. Knobler.3 1Kaplan Medical Center, Heart Institute, Rehovot, Israel, 2Haifa
University, Haifa, Israel, 3Kaplan Medical Center, Metabolic Diseases Unit, Rehovot,
Israel
Background: Coronary artery disease (CAD) is the leading cause of morbidity and
mortality in patients with diabetes mellitus (DM). Early identification of high-risk
subgroups followed by appropriate therapy may improve survival. The aims of this
study were to identify clinical predictors of abnormal myocardial perfusion imaging
(AMPI) and to evaluate the prognostic value of AMPI in asymptomatic DM pts.
Methods: Between January 1999 and February 2003, 1587 DM pts underwent a stress
Tl-201 SPECT. Of these, 302 pts fulfilled the following inclusion criteria: asymptom-
atic, a minimum of 1 year follow up and available clinical data including DM duration,
treatment, complications, albuminuria and blood levels of: creatinine, hemoglobin A1C,
HDL (HDL-C) and LDL cholesterol, triglicerids. Cardiac events (CE) were classified as
hard (HEcardiac death, myocardial infarction) and soft (SEunstable angina,
coronary revascularization).
Results: An AMPI was present in 62.9% of the pts with either fixed (23.2%)or
reversible (39.7%) Tl-201 defect patterns. Pts with AMPI compared with pts with
normal myocardial perfusion were more often males (79% vs 41%, p 0.0001), had
higher prevalence of hyperlipidemia (59% vs 41%, p 0.002), peripheral vascular
disease (PVD) (51% vs 36%, p 0.01), an abnormal resting ECG (59% vs 19%, p
0.0001), smoking (51% vs 36%, p 0.0004), a previous history of CAD(HX)(65% vs
13%, p 0.0001) and a lower HDL-C (4111 vs 4613 mg/dl, p 0.001). The best
predictive model of an AMPI included male gender, HX, smoking, PVD and abnormal
resting ECG. Within the follow-up period (861384 days) 48 pts had cardiac events
(HE13, SE35), 41 of them (83.5%) had an AMPI (chi-square 12.4, p 0.0001).
The best predictive model of total CE included PVD, low creatinine clearence and
AMPI. An AMPI had a significant incremental predictive value over the clinical and
laboratory data (chi-square 8, p 0.005).
Conclusions: Abnormal myocardial perfusion is frequently present in asymptomatic
DM pts. Male gender, hyperlipidemia, a previous history of CAD, smoking, PVD,
abnormal resting ECG and a low HDL-C blood level characterize a group of pts having
an AMPI. Asymptomatic DM pts characterized by PVD, low creatinine clearence and
AMPI are a high-risk group for cardiac events.
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7.21
Characteristics of stress induced ischemia in symptomatic versus asymptomatic
populatoin without known coronary artery disease: correlation with age, gender
and functional capacity.
I. Mats1, A. Solodky1, T. Ben-Gal1, A. Battler1, N. Nili Zafrir.2 1Rabin Medical Center,
Cardiology Department, Petah Tikva, Israel, 2Rabin Medical Center, Beilinson Campus,
Petah Tikva, Israel
According to ACC/AHA guidelines asymptomatic patients with relatively low prevalence of
CAD, Myocardial Perfusion Imaging (MPI) is currently not recommended, as its prognostic
yield is unclear. The aim of this study was to compare between symptomatic versus asymptom-
atic patients without known CAD referred for stress MPI in terms of prevalence of ischemia,
gender, functional capacity and risk factors.
Methods: During 2002 to 11.03 we consecutively identified 1630 patients without known CAD
or any cardiac abnormality, who were referred for MPI. Of whom, 1309 (80%) pts (symptom-
atic) referral reason was angina or angina equivalent symptoms. The remainder 321 (20%) pts
(asymptomatic) the referral reason was positive or unequivocal exercise test or for exclusion of
CAD. Comparisons between the 2 groups were performed.
Results: see in the table
Conclusions: The asymptomatic population is younger, male, and has a better exercise
tolerance. In spite of this, the prevalence of stress-induced ischemia in asymptomatic
patients referred for MPI was similar to symptomatic patients suspected of CAD.
However, the severity of ischemia was more significant in the symptomatic patients.
table
Variable Symptomatic, n1309 (%) Asymptomatic, n321(%) p value
Age 62.412.8 57.712.3 0.01
Gender (men) 607(46) 208(65) 0.01
Diabetes Mellitus 270(21) 50(16) 0.01
Hypertension 651(50) 140(44) 0.05
Hyperlipidemia 484(37) 113(36) NS
Family history 125(9) 31(10) NS
Smoker 192(15) 37(12) NS
MPHR(%) 92.69.3 947.4 0.01
METS 9.42.8 10.72.9 0.01
St depression 239(18) 122(38) 0.01
TID 119(9) 28(9) NS
Lung uptake 150(11) 35(11) NS
Ischemia 325(25) 69(21) NS
Degree Ischemia 1.530.66 1.390.62 0.01
LVEF 58.611.1 58.87.3 NS
7.22
Correlation between clinical-angiographic and scintigraphic markers in prediction
of perfusion and kinetic improvement after mechanical revascularization in acute
myocardial infarction.
E. Elisabetta Varani1, M. Balducelli1, S. Severi2, A.L. Patroncini3, G. Vecchi1, C.
Gatti1, C. Corbelli2, R. Casanova3, A. Maresta.1 1S. Maria delle Croci, Cardiology,
Ravenna, Italy, 2O.C. per gli Infermi, Nuclear Medicine, Faenza, Italy, 3O.C. per gli
Infermi, Cardiology, Faenza, Italy
Purpose of the study is to evaluate which of the clinical-angiographic parameters of
acute ischemic estension and efficacy of reperfusion in AMI treated with primary PCI
are predictive of infarct size and one month improvement of left ventricular function. To
assess this issue we evaluated 35 patients, 32 males, mean age 6111 years with two
rest sestamibi gated SPECT, the first 4 to 6 days and the second 30 to 40 days after
primary PCI.
We considered the following parameters: AMI location, number of ECG leads with ST
elevation (N° ST), the sum in mm of ST elevation (S mm ST), % ST resolution in the
ECG up to 60 minutes after vessel reopening (D% ST), total ischemia duration
(symptom onset-balloon time; TI), peak CK MB elevation (MB max) and its timing, pre
and post-PCI TIMI flow in IRA, corrected TIMI frame count (cTFC), myocardial
perfusion grade (MPG), initial and late infarct size (% of black out on total pixel count,
%BO), initial and late EF, initial and late segmental kinetic defects.
Results: N° ST, S mm ST and MB max among initial ischemic extension parameters
have significant linear correlation one with another and with initial perfusion defect. TI
£ 240 min is related to a lower cTFC, a better late EF and smaller infarct size. D% ST
3 70% is present in 74% of patients and is associated with a smaller late perfusion
defect. MPG 3, present in 77% of patients is significantly correlated with a better late
EF. cTFC has a statistically significant linear correlation with late EF. A late EF 3 50%,
present in 54% of patients, is associated with the following parameteres: S mm ST
(126 vs 199 mm, p.028), D% ST (8917 vs 6722%, p.002), TI (15180 vs
273176 min, p.010), MBmax (183156 vs 317177 ng/ml, p.023), initial EF
(505 vs 4011%, p.001), initial (1510 vs 3013%, p.001) and late BO
(12.510 vs 2412%, p.006). An improvement in EF between the first and the
second SPECT was seen in 21/35 pts (60%). These pts showed a shorter TI ( 165  82
vs 271 193, p .003) and a lower cTFC ( 21 6 vs 31 14, p .02). In 14 patients
(40%) we observed a reduction of BO associated with a faster CK-MB peak and a
bigger infarct size.
Conclusion: improvement of perfusion parameters and left ventricular function is
frequent one month after primary PCI in AMI. A total ischemia duration £ 240 min,
cTFC £ 21 and MPG  3 are the best indicators of late EF and improvement of EF.
7.23
Assessment of acute myocardial infarction evolution in patients undergoing
primary angioplasty or thrombolytic therapy: a gated-SPECT longitudinal eval-
uation study.
C. Corrado Cittanti1, M. Valgimigli2, M. Giganti1, P. Malagutti2, G. Percoco2, E.
Bagatin1, S. Panareo1, N. Avigni2, R. Ferrari2, L. Feggi.1 1Nuclear Medicine Section,
University of Ferrara, Ferrara, Italy, 2Cardiology Section, University of Ferrara, Ferrara, Italy
Aim: it’s generally recognized a lack of informations concerning the natural history of
hypoperfused myocardial territories after an acute myocardial infarction (AMI) treated with
percutaneous or pharmacological revascularization. The aim of this study was to assess the
evolution of both perfusion defect and left ventricular function simultaneously, from the
acute to the stable phase of AMI using rest myocardial gated-SPECT imaging (GS).
Methods: thirtyfive patients (29M/6F-mean age 6213yr) without history and/or ECG
evidence of previous myocardial necrosis underwented successful primary angioplasty
(28) or systemic thrombolysis (7) for AMI. All subjects were studied with rest
99mTc-sestamibi GS (740MBq) after 48-72 hours, 2 and 6 months from the acute event.
Summed rest score (SRS), end diastolic volume (EDV), end systolic volume (ESV) and
left ventricular ejection fraction (LVEF) were obtained for all scintigraphic studies.
Results: from 48-72 hours to 2 months studies an increase in LVEF values (48.614.6
vs 54.812.7; p0.01) and a reduction in both SRS (15.88.3 vs 7.86.8; p0.001)
and ESV (70.143.9 vs 62.144.3; p0.05) data were observed. Moreover no
significant statistical differences were noticed from early images to 2 months studies in
EDV estimates and between 2 and 6 months studies for all the considered parameters.
Finally the correlation between the early assessed SRS and its differential values
obtained as SRS at 2 months less SRS at 48-72 hours showed a r0.58 with a pns;
the same analysis on LVEF values demonstrated similar findings (r0.52 with pns).
Conclusion: the first interesting data emerging from this study is the significant
improvement in terms of ESV, LVEF and SRS values noticed between early
post-revascularization studies and 2 months scintigraphy. This aspect may be related to
a variable quota of stunned myocardium with an associated impairment of microvas-
cular environement and, likely, of sestamibi driving potentials in the post-acute phase
of the ischaemic event. Therefore on the basis of early GS data alone the presence of
this unpredictable quota may lead to a variable overestimation of both scar area
extension and left ventricular function impairment probably limiting the prognostic role
of a rest myocardial scintigraphy if performed a little later an acute coronary syndrome.
Moreover the resolution of these phenomenons seems to occur in the majority of cases
during the first 8 weeks from the AMI. Larger prospective trials are mandatory to
confirm these preliminary findings and to assess their potential impact in clinical
practice.
7.24
Flow-mediated brachial artery vasodilation rules out coronary artery disease in
patients with peripheral artery disease.
P. Pasquale Perrone Filardi1, A. Cuocolo2, G. Storto2, G. Brevetti1, S. Dellegrottaglie1,
L. Corrado1, M. Cafiero1, M. Polimeno1, A. Zarrilli1, M. Chiariello.1 1“Federico II”
University, Cardiology, Naples, Italy, 2“Federico II” University, Nuclear Medicine,
Naples, Italy
Peripheral artery disease (PAD) is often associated with coronary artery disease (CAD)
and such association substantially worsens prognosis. Thus, ruling out CAD is very
relevant in patients with PAD.
Aim. To evaluate whether assessment of brachial artery flow-mediated dilation (FMD)
by ultrasound imaging predicts absence of significant CAD in patients with documented
PAD.
Methods. We studied 44 (age 6210) consecutive PAD patients (ankle-to-brachial
index0.90; mean 0.70.1) asymptomatic for CAD with FMD and dipyridamole (0.74
mg/kg/min) 99mTc-MIBI SPECT within one week while off drugs. SPECT myocardial
images were used to measure regional myocardial uptake using a 17 segment-model.
Results. In PAD patients FMD was significantly reduced compared to 18 age-matched
controls (6.82.1% vs 11.83.1%, p0.0001). Quantitative SPECT was abnormal
(either reversible or fixed defect) in 17 (39%) patients. In patients with abnormal
SPECT, FMD was significantly reduced compared to patients with normal SPECT
(6.02.3% vs 7.31.8%, p0.04). A multivariate analysis including cardiovascular
risk factors, ankle-to-brachial index and FMD showed that only the latter was
significantly associated with abnormal SPECT (OR0.63, 95%; CI 0.43-0.3; p0.02).
ROC analysis examining the ability of FMD to predict CAD yielded an area under the
curve of 0.74 (p0.009). An FMD value  6% yielded a 92% negative predictive
accuracy to rule out an abnormal SPECT, with 79% sensitivity, 73% specificity and
58% positive predictive accuracy.
Conclusions. FMD is highly predictive of normal myocardial SPECT in asymptomatic
PAD patients. Thus, FMD may represent a useful screening test for CAD in PAD
patients.
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7.25
Long-term evolution of myocardial perfusion pattern at 99mTc-MIBI SPECT in
stable CAD patients maintained on medical teraphy.
C. Claudio Marcassa1, R. Campini2, P. Calza2, P. Giannuzzi.1 1S. Maugeri Fnd IRCCS,
Cardiology, Veruno, Italy, 2S. Maugeri Fnd IRCCS, Nuclear Medicine, Veruno, Italy
Background. Few data exist about the evolution of the myocardial perfusion pattern
over time in pts with stable ischemic heart disease (IHD).
Aim. Aim of the study was to evaluate changes of stress-rest myocardial perfusion in
stable pts with stable IHD in medical treatment.
Methods. 174 consecutive pts (age 609, 68% males) with known or suspected IHD,
who had a follow-up stress-rest myocardial perfusion SPECT (MPI) being clinically
stable in medical therapy (infarction, revascularization, and changes in frequency/
severity of angina were excluded) were evaluated. At the time of the study 1, the mean
number of coronary risk factors was 1.81.0, 37% had typical angina, 32%, had a
previous MI, 45% had documented coronary stenoses and 33% had a previous
CABG/PTCA; LVEF was preserved (50%) in 85% of pts. All pts hada 2-day
stress-rest MPI with MIBI. The regional tracer distribution on the polar map was
compared with a normal gender-matched data-base: differences between studies were
considered significant when the extent of perfusion defect (PD) was 5% of LV
surface; ischemia was considered severe for defects reversibility 15% of LV surface
and moderate when 5% and  15%.
Results. At study 1, a rest PD was observed in 66 pts (38%) and a reversible PD was
documented in 49 pts (28%). The follow-up study (study 2) was performed on average
2.70.8 yrs after the study 1. Medical therapy in the follow-up included: NTG in 55%
of pts, B-blockers in 50%, ca-antagonists in 60%, and ACE-inhibitors in 20%. In all pts,
the same stress of study 1 was performed (dipyridamole in 91 pts, 52%). No significant
differences between study 1 and study 2 were observed in the incidence of chest pain,
ischemic ECG changes, in the hemodynamic response (blood pressure and heart rate)
during stress as well as in the extent of rest PD. On study 2, stress perfusion worsened
in 46 pts (26%): in 10 pts the ischemic area was larger than in study 1, and in 36 pts
a new reversible PD (moderate in 30/36 (83%) pts and severe in 6/36 (17%) pts)was
documented. In 11 additional pts (6%), the ischemic area at study 2 reduced. A trend
was observed between the number of risk factors and the worsening of stress MPI (24%,
31% and 59% in pts with 2, 2 or 2 risk factors, respectively, p0.03).
Conclusions. Despite medical therapy and in clinical stability, stress MPI worsened in
26% of pts. The worsening was more frequent in pts with 2 risk factors; in this subset
of pts, even if clinically stable, a stress MPI after 2 yrs could be suggested to assess
CAD progression and identify pts at greater risk of events.
7.26
Prognostic value of 99Tc-tetrofosmin SPECT exercise myocardial scintigraphy
after incomplete revascularization with coronary stenting.
A. R. Alfredo Galassi, C. Grasso, S. Azzarelli, E. Leotta, S. Moshiri, C. Tamburino.
Ferrarotto Hospital, Cardiology Division, Catania, Italy
Backgrounds. We evaluate the prognostic value of exercise myocardial scintigraphy in
patients who undergo incomplete percutaneous coronary revascularization.
Methods. In 322 consecutive patients with multivessel coronary artery disease who
underwent incomplete revascularization with coronary stenting, an exercise 99mTc-
tetrofosmin SPECT scintigraphy was performed prospectively 4 to 6 months after the
revascularization procedure. Follow-up was defined as time from scanning until a
cardiac event occurred, and lasted up to 84 months.
Results. Patients with normal scan were at low risk of cardiac events as compared to
patients with mildly and severely abnormal scan (yearly event rate 1.5% vs 5.1 and
8.5%, respectively, p0.01). The Kaplan-Meyer survival curves showed a significant
difference in hard, soft and composite event-free survival between patients with normal,
mildly abnormal and severely abnormal scan (p0.01, p0.05 and p0.01, respec-
tively). With the use of Cox proportional-hazards analysis, nuclear data provided
significant incremental prognostic value for cardiac events as compared to clinical,
angiographic, and exercise test.
Furthermore, when patients were stratified on the basis of residual ischemia or
myocardial necrosis found on exercise 99mTc-tetrofosmin SPECT scintigraphy,
Kaplan-Meyer survival curves showed a significant difference in hard event-free
survival between patients with myocardial necrosis and ischemia, necrosis alone,
ischemia alone or normal scan (p0.05).
Conclusions. In patients with incomplete revascularization procedures exercise myo-
cardial scintigraphy provided both significant independent information concerning the
subsequent risk of cardiac events, with an annualized event rate 2% for patients with
a normal scan, and an incremental prognostic information after adjusting for clinical,
angiographic and exercise variables.
7.27
A prospective, multi-center trial to identify the prevalence of inducible ischemia in
patients presenting with diabetes and without known coronary artery disease:
preliminary results.
W. Acampa1, A. Ferro1, M. Petretta2, M. Salvatore1, A. Alberto Cuocolo.1 1Department
of Diagnostic Imaging, University Federico II, Napoli, Italy, 2Department of Cardiol-
ogy, University Federico II, Napoli, Italy
Aim: Coronary artery disease (CAD) is the leading cause of morbidity and mortality in patients
with diabetes mellitus and these patients have an elevated prevalence of silent myocardial
ischemia. This study assessed the prevalence of inducible ischemia by sestamibi SPECT in
patients with diabetes without history of CAD and/or evidence of myocardial infarction.
Methods: We studied 126 consecutive patients with at least a five-year history of
diabetes mellitus without history of myocardial ischemia or evidence of myocardial
infarction represented on ECG. A computer program (CADENZA™, Advanced
Euristic) was used to determine pre- and post-test likelihood of CAD. Beside diabetes,
the program considered for analysis of pre-test likelihood of CAD the following
variables: age, sex, angina symptoms classification, blood pressure, serum cholesterol,
smoking history, resting ECG and family history. All patients underwent rest and
dipyridamole (0.142 mg/kg/min intravenous over 4 minutes) stress sestamibi SPECT.
Both rest and stress sestamibi studies were interpreted by 2 independent observers
utilizing a 17-segment scoring system to determine summed stress score (SSS), summed
rest score (SRS) and summed difference score (SDS). Based on this model, SPECT
studies with an SRS or SSS3 were considered abnormal. The SDS was used to
determine the presence of inducible ischemia and to assess the extent and severity of
perfusion defects (mild, moderate and severe).
Results: On the basis of CADENZA, diabetic patients were divided into 3 groups: low
(62 patients), intermediate (44 patients) and high (20 patients) pre-test likelihood of
CAD. Inducible ischemia at SPECT was present in 30 patients (48%) with low, in 20
(45%) with intermediate and in 10 (50%) with high pre-test likelihood of CAD
(P0.96). The extent and severity of myocardial ischemia was not different in the 3
groups of patients (all PNS). Taking in account SPECT results, 4/62 (36%) patients
with low pre-test likelihood shifted in intermediate post-test likelihood and 30/44 (68%)
patients with intermediate pre-test likelihood shifted in low post-test likelihood
(P0.05).
Conclusion: The preliminary results of this prospective multi-center trial, demonstrate
that in diabetics without known CAD, patients with low pre-test likelihood had similar
prevalence of myocardial ischemia at sestamibi SPECT imaging as compared to those
with intermediate and high pre-test likelihood. In addition, they suggest that SPECT is
potentially useful to add further information in assessing the likelihood of CAD in
patients with diabetes mellitus.
7.28
Impact of ACC/AHA guidelines for risk stratification and management of patients
undergoing vascular surgery (vs):a prospective study.
P.L. Pierluigi Pieri1, R. Berta2, G. Moscatelli3, F. Buccoliero.4 1M. Bufalini Hospital,
Nuclear Cardiology, Cesena, Italy, 2“ Maggiore” Hospital, Division of General Surgery,
Bologna, Italy, 3“M. Bufalini”, Nuclear Medicine, Cesena, Italy, 4“Bufalini” Hospital,
2nd II Division of General Surgery, Cesena, Italy
Aim: To assess the clinical impact of the ACC/AHA Guidelines for risk stratification
and management of pts undergoing vascular surgery in a prospective manner..
Methods: 201 consecutive pts (age 70.5 range 40-85) who were candidates for VS (101 carotid
endo-aterectomy and 100 aortic or peripheral vascular surgery) were prospectively evaluated based on
the ACC/AHA guidelines according to a risk stratification which accounting for: 1) clinical predictors of
increased perioperative risk (major, intermediate and minor), 2) surgery specific risk and 3) functional
capacity. Further assessment of the ischemic cardiac risk was assessed by Stress -SPECT- MPI (
GATED) according to the ACC/AHA Guidelines. Stress MPI images were evaluated as normal or
Fixed(F)/Reversible(R)/Fixed  Rev.(FR) defects and their extent and severity.
End Points: Cardiac death, M.I., Unstable angina and CHF occurring within 30 days
from surgical procedure.
Results: Clinical risk factors were present as follows: Major: 1 patient; Intermediate: 75 pts;
Minor: 90 pts; No risk factors:35 pts..
Among all patient evaluated, stress MPI was performed according to the ACC/AHA
guidelines in 43 pts (21%)(Dipyridamole n33; exercise:n10) and was abnormal in
27 pts: F:2 pts; R(not extensive) in 17 pts; FR in 7 pts. In one pt ischemia was
extensive. In 16 pts, MPI was normal.
Clinical management: In one patient, vascular surgery was cancelled because of his high
cardiac risk; Only one patient was further evaluated with coronary angiography because
of extensive ischemia.
In the remaining pts with mild/moderate ischemia, coronary angiography was not
performed and medical therapy was optimized (beta-blockers).
Perioperative Outcome: None of the pts experienced cardiac death. One pt had M.I. in
the perioperative phase. One pt developed unstable angina.
Conclusions: The results of this study show that in pts undergoing vascular surgery;
1) A risk stratification based on the rigorous application of ACC/AHA guidelines is associated
with a very low risk of perioperative cardiac events (0.5% hard events and 0.5% soft events);
2) A selected use of stress myocardial perfusion imaging in pts at higher clinical risk
improve the confidence of physicians in the management of pts with CAD;
3) Coronary angiography and myocardial revascularization can be avoided before
vascular surgery in most of pts with CAD, when the extent of ischemia (as determined
by MPI) is mild to moderate in degree and adequate medical therapy and monitoring are
employed.
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7.29
Incidence of post-exercise stunning evaluated by Gated-SPET myocardial perfu-
sion imaging A Multicenter Study.
E. Inglese1, C. Claudio Marcassa2, G. Medolago3, A. Imperiale4, ML. De Rimini5, F.
Bertagna6, P. Sullo7, M. Lupo8, A. Ferro9, M. Cappagli.10 1Ospedale della Carita`,
Nuclear Medicine, Novara, Italy, 2S. Maugeri Fnd IRCCS, Cardiology, Veruno, Italy,
3Gen.Hosp, Nuclear Medicine, Bergamo, Italy, 4Florence University, Nuclear Medi-
cine, Florence, Italy, 5Monaldi H., Nuclear Medicine, Naples, Italy, 6Spedali Riuniti,
Nuclear Medicine, Brescia, Italy, 7Nuclear Medicine, Caserta, Italy, 8Nuclear Medicine,
Palermo, Italy, 9Un. Federico II, Nuclear medicine, Naples, Italy, 10Nuclear Medicine,
La Spezia, Italy
Aim: 1) to determine the incidence of post-exercise stunning (PES) in a high risk population and,
2) to investigate the outcome of pts with PES during a 2 years follow-up.
Methods: from May 2002 to April 2004, 10 centers prospectively enrolled 498 male pts
(637 yrs) with intermediate-to-high pre-test likelihood of CAD. Pts with LVEF 35%,
advanced non-ischemic heart diseases, procedures of revascularization  6 months or
unable to reach the 85% of maximum predicted heart rate, were excluded. All pts
underwent rest and exercise gated-SPECT with 99mTc-labeled agents in separate days.
Regional perfusion (RP) and wall motion (RWM) in 9 myocardial segments were
visually classified on a five-point scoring scale (0normal to 4severe); summed
perfusion and wall motion scores at rest and exercise, as well as their difference, were
calculated.. Volumes and LVEF were calculated with commercial softwares. Data were
collected on the GICN web site, and a data-base was automatically generated. Ischemia
was defined as a SDS  1; PES was defined as a decrease of more than 5 LVEF units
after stress and/or a difference RWM score 1.
Results: Dyslipidaemia was documented in 65%, hypertension 57%, diabetes 24%,
smoking 43%. Previous MI was documented in 44 % of pts (24% inferior, 14% anterior)
and previous CABG/PTCA procedures were performed in 16% and 34% of pts, respect.
Nineteen percent of pts had typical angina, 49% were asymptomatic. The EST was
positive in 150 pts (32%) and negative in 199 pts (43%). On SPECT images, ischemia
was found in 229 pts (49%). PES was documented in 111 pts (22%); PES was observed
in 24% of pts with reversible PD and in 18% of pts without (ns). PES pts showed
significant increase in EDV and a greater RWM difference score (all p0.001).
However, no differences in positive EST, hx of previous MI, CABG/PTCA were
observed between pts with and without PES.
Conclusions: In a large population of male pts routinely studied for diagnostic purposes
and/or risk stratification, PES was documented in 22% of pts. PES was unrelated to the
presence of previous MI, ECG changes or stress-induced differences in perfusion
scores. The follow-up of these pts is ongoing.
7.30
Usefulness of thallium-201 myocardial perfusion SPECT images in type 2 diabetic
patients without typical chest pain.
H. Hiroshi Fukuda, T. Kunimasa, T. Furuhashi, M. Moroi. Toho University Ohashi
Hospital, Division of Cardiovascular Medicine, Tokyo, Japan
Background: Diabetic patients with coronary artery disease often have no typical chest
pain. The incidence of coronary artery disease in diabetic patients without typical chest
pain is unknown. The purpose of this study was to investigate usefulness of Thallium
(Tl)-201 stress myocardial perfusion SPECT images (MPI) in type 2 diabetic patients
with no typical chest pain and no prior coronary artery disease.
Methods: Consecutive type 2 diabetic patients (n 116, male 66, age 64,
asymptom 29, atypical chest pain 17, abnormal electrocardiogram 82, hemodi-
alysis 22) were followed up for 31 months after Tl-201 pharmacologic stress MPI.
Follow up time was censored at the occurrence of acute coronary syndrome (ACS) or
revascularization. Defect score was calculated using a 20-segment model and a 0-4
scale.
Results: SPECT images showed abnormal (defect score 3) in 23 (20%) and normal
in 93 (80%) patients. ACS occurred in 3 (3%) and revascularization occurred in 5 (4%)
patients. There is a significant difference in Kaplan-Meier curves between patients with
perfusion defects and those with normal SPECT images (P 0.0013). Cox regression
analysis was shown in Table.
Conclusins: Perfusion defect of Tl-201 pharmacologic stress MPI is a good predictor of
coronary events in type 2 diabetic patients with no typical chest pain and no prior
coronary artery disease.
Cox regression analysis
Hazard ratio 95%CI P value
defect score3 7.369 1.760–30.855 0.0063
mean washout rate35% 2.140 0.510–8.973 0.2982
atypical chest pain 0.896 0.110–7.299 0.9185
abnoraml electrocardiogram 0.746 0.178–3.125 0.6885
7.31
A selective angiotensin receptor antagonist, termisaltan, produced regression of
left ventricular hypertrophy with the improvement of myocardial perfusion and
fatty acid metabolism.
W. Watanabe Yasuhi1, S. Akihiro1, Y. Akio1, K. Ryou1, T. Kimio1, W. Yasunori1, T.
Yasuhiko2, E. Nariaki.2 1Hitachi General Hospital, Cardiovascular Medicine, Hitachi,
Japan, 2Taga General Hospital, Internal Medicine, Hitachi, Japan
Backgrounds: Although myocardial perfusion and fatty acid metabolism are reportedly
impaired in myocardial hypertrophy, but there are few reports describing the changes in
myocardial perfusion and fatty acid metabolism by a selective angiotensin receptor
antagonist. We investigated the nuclear scintigraphic changes with left ventricular
hypertrophy (LVH) under the influence of a selective angiotensin receptor antagonist,
termisaltan.
Methods: The subjects consisted of 36 patients (9 women, mean age 57.56.3 years)
in our hospital who were diagnosed as essential hypertension with left ventricular
hypertrophy (LVH) and who had not been treated with any antihypertensive medication
prior to the study. Moreover, all patients underwent dual single-photon emission
computed tomography (SPECT) using 123I-BMIPP and 201Tl imaging at rest and other
noninvasive studies (two-dimensional echocardiography for left ventricular mass index
(LVMi) analysis and BNP at rest) as well as before and after 6 months termisaltan
administration. SPECT findings were graded in 17 segments on a four-point scale from
3(good) to 0(none) and assessed as a summed score (uptake score). Termisaltan was
administered at a mean final dose of 10.4  2.1 mg/d for over 6 months and resulted
in a significant decrease of systolic and diastolic blood pressures.
Results: Systolic blood pressure significantly decreased from 150.1  20.2 to 130.3 
9.0 (p 0.0001), and the mean LVMi decreased significantly from 177.7  49.7 to
157.3 54.5 (p 0.0001). But BNP had not decreased significantly from 112.5 49.3
to 99.6  41.5.Moreover, each uptake score of BMIPP and Tl increased (BMIPP; from
46.03  3.0 to 47.4  2.9 (p 0.005) and Tl; from 44.9  4.0 to 46.9  3.2 (p
0.005)).
Conclusion: Termisaltan produced regression of left ventricular hypertrophy with the
improvement of myocardial perfusion and fatty acid metabolism. Our findings suggest
that pharmacological blockade of angiotensin II receptors by termisaltan could improve
LVH in never-treated essential hypertension patients, which may relate to the improve-
ment of the improvement of myocardial perfusion and fatty acid metabolism.
7.32
Marked dispersion of cardiac FDG uptake for medical examination under fasting
state by the whole body from consecutive 564 cases in Japanese.
W. Watanabe Yasuhi1, S. Akihiro1, Y. Akio1, K. Ryou1, W. Yasunori1, T. Kimio1, T.
Yasuhiko2, E. Nariaki.2 1Hitachi General Hospital, Cardiovascular Medicine, Hitachi,
Japan, 2Taga General Hospital, Internal Medicine, Hitachi, Japan
Background: Positron emission tomography (PET) with 18F fluoro 2deoxy D glucose
(FDG) is a non-invasive method for surveying the whole body and detecting various
malignancies. And for patients with advanced ischemic heart disease, PET is a
reimbursable method for identifying those suitable for revascularization. In general,
under fasting state myocardial metabolism was dependent in free fatty acid. Thus, it is
thought that cardiac FDG uptake had been decreased remarkably under fasting and
resting state. Although cardiac FDG uptake for medical check had been found to a
certain extent, there were no investigated data. The purpose of the present study is to
examine the cardiac FDG uptake under fasting and resting state.
Methods: A total of consecutive 564 subjects underwent whole-body FDG PET studies in our
hospital over 6 months period. All studies had been worked out under fasting over than 6 hours
and enough resting before PET study. All subjects had no underlying heart disease and no
previous cardiac events. And subjects with uncontrolled diabetes mellitus or over than high blood
sugar level (130 mg/dl) had been excluded. The uptake of cardiac FDG was scored semi
quantitatively from 3 (equal to brain uptake) to 0 (none) in whole left myocardium (cardiac
uptake score; CUS). We examined the relation analysis between CUS and the patient’s
characteristics (age, gender, body mass index (BMI), fasting blood sugar (FBS)).
Results: (See table)
Conclusion: Our study revealed marked dispersion of cardiac FDG uptake for medical
examination under fasting state. Moreover cardiac FDG uptake is not related to BMI,
FBS and subject characteristics. Recently, myocardial glucose metabolic complexities
in cardiac FDG imaging had been reported. Some of them referred a measure of the rate
of FDG accumulation may be just that a measure of FDG accumulation and not a
measure of metabolic rate. Our findings might support their suggestions and suggest
some of unknown factors in myocardial glucose utilization.
Table
0 1 2 3
Cases(%) 252(44.7) 64(11.3) 72(12.8) 176(31.2)
BMI 23.1 22.5 23.1 23.1
FBS 96.8 99.3 98.0 98.6
Gender/Age no differences no differences no differences no differences
CUS;Cardiac uptake score BMI;Body mass index FBS;fasting blood sugar
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7.33
Parametric imaging for myocardial blood flow and perfusable tissue fraction with
[O-15]water and PET.
H. Hiroshi Watabe, N. Teramoto, Y. Ohta, Y. Kou, T. Hayashi, H. Iida. National
Cardiovascular Center, Research Institute, Suita, Japan
[O-15]water has several advantages such as ability of repeated scan and is ideal tracer to measure
blood flow. Regional MBF(myocardial blood flow) can be measured with [O-15]water and PET
using one-tissue compartment model with perfusable tissue fraction (PTF), which provides MBF
value that is free from partial volume effect. However, due to the short scan period and the small
distribution volume of [O-15]water in the myocardium, image quality of [O-15]water is limited,
which makes difficult to compute MBF value at the voxel level. We developed a method for
generating parametric images of MBF, PTF and arterial blood volume (Va) with [O-15]water
and PET. The method was based on basis function method (BFM) to linearize solution of
one-tissue compartment model, which results in more stable and computationally much faster
than conventional non-linear least squares fitting method(NLM) to estimate parameters.
In order to validate BFM, series of PET studies were performed on pigs (n8). PET scans with
[O-15]water were performed with varying doses of adenosine (5-7 scans for each pig).
Myocardial region were segmented into 9 regions of interest (ROI) ts of myocardium regions
MBF, PTF and Va values of 9 regions for each scan were computed by BFM and NLM, and
estimated parameters by two methods were compared.
The figure shows comparisons between NLM and BFM for each each regions. As
shown in this figure, the estimated MBF, PTF, and Va values by BFM and NLM were
highly correlated.
In conclusion, BFM is able to produce parametric images of MBF, PTF and Va with
[O-15]water and PET. Parametric images could be useful to diagnose regional
myocardial perfusion abnormalities.
Comparison between NLM and BFM
7.34
Prognostic factors of myocardial perfusion imaging in medically treated patients
with acute myocardial infarction having nonviable myocardium.
H.S. Hee-Seung Bom, H.C. Song, J.J. Min, Y.J. Heo. Chonnam National University
Hospital, Nuclear Medicine, Gwangju, Korea, Republic of
Aim: To evaluate prognostic factors of myocardial perfusion imaging in patients with
acute myocardial infarction showing nonviable myocardium on myocardial perfusion
imaging hence treated medically.
Methods: Subjects were 30 patients (26 males, 4 females) of acute myocardial
infarction treated medically. They underwent myocardial perfusion imaging within 1
month of acute myocardial infarction attack using Tc-99m-tetrofosmin and adenosine,
which showed nonviable myocardium on infarcted lesions. They were followed for
30.615.7 months.
Results: Four cardiac events were developed including 2 cardiac deaths and 2 recurrent
myocardial infarctions. Univariate analysis showed uptake of infarct area (P0.03) and
size of necrotic area (P0.05) as significant prognostic factors. Multivariate analysis
showed that uptake of infarct area was the only significant factor.
Conclusion: Lower uptake in nonviable myocardium is related to poor prognosis in
medically treated patients with acute myocardial infarction having nonviable infarction.
7.35
Prognosis of patients with positive exercise test and normal myocardial perfusion
SPECT.
JH. Seo1, J. Jae-Tae Lee1, JH. Bae1, SY. Jeong1, BC. Ahn1, SC. Chae2, KB. Lee.1
1Kyungpook National University Hospital, Nuclear Medicine, Taegu, Korea, Republic
of, 2Kyungpook National University Hospital, Cardiology, Daegu, Korea, Republic of
BACKGROUND: Exercise SPECT myocardial perfusion imaging (Ex-MPI) is re-
garded as a critical predictive technique in patients with coronary artery disease (CAD)
particularly who have higher-function capable of performing exercise testing. But
sometimes in clinical practice, we encounter equivocal situations of discordant findings
between exercise ECG and MPI. In currant study we evaluated the prognosis of subjects
with positive ECG and normal MPI findings, and predictive factors for future cardiac
events were also studied.
METHOD AND SUBJECTS: A total of 2571 Ex-MPI studies were reviewed over a
period of 3 years. Subjects were followed for more than 2 years (24-56 months, mean
35months) for cardiac events after exercise testing. The cardiac events were defined as
hard events (cardiac death and nonfatal myocardial infarction (MI)) and soft events
(aggravation of CAD necessitating revascularization, severe congestive heart failure
necessitating hospital admission for treatment). We have evaluated age, sex, typical
angina pain, rest ECG abnormalities, hypertension, diabetes mellitus (DM), serum
levels of cholesterol and LDL, smoking history, history of cerebrovascular disease
(CVD) and peripheral artery disease (PAD), and rest left ventricular ejection fraction
(LVEF) as clinical variables.
RESULTS: Of 83 subjects with positive ECG and normal MPS findings, 6 were
considered as false negative results confirmed with coronary angiography at the time of
MPI study. There were 77 patients (mean age 52years, 39 males and 38 females) with
positive ECG and normal MPI results. During the follow-up period, there were 3 cardiac
events (event rate 1.9% per year, no cardiac death but 2 nonfatal MIs (event rate 1.3%
per year) and 1 soft event (event rate 0.6% per year) out of 77 studies. 2 patients out of
39 males (5.1%), and 1 out of 38 females (2.6%) had cardiac events. All cardiac events
were observed within 2 years. 1-year cardiac event rate was 0.6% (1 event during the
first year) and 2-year cardiac event rate was 1.9% (3 events during 2 years). Among
clinical factors, male sex, typical chest pain and smoking history at the time of MPI
were predictive of cardiac events.
CONCLUSION: Patients with positive ECG and negative Ex-MPI results have very
low risk for cardiac events. Nevertheless, the cardiac events cannot be excluded totally
in some cases.
7.36
Detection of myocardial ischemia with myocardial perfusion SPECT in patients
with diabetes mellitus.
JH. Seo1, J. Jae-Tae Lee1, JH. Bae1, SY. Jeong1, BC. Ahn1, SC. Chae2, KB. Lee.1
1Kyungpook National University Hospital, Nuclear Medicine, Taegu, Korea, Republic
of, 2Kyungpook National University Hospital, Cardiology, Daegu, Korea, Republic of
BACKGROUND: Diabetes mellitus (DM) is a critical disease associated with higher
rates of cardiovascular morbidity and mortality. Atherosclerosis accounts for 65-80% of
all deaths in diabetic patients and patients with DM are known to show high prevalence
of coronary artery diseases (CAD). In currant study we have evaluated the incidence of
scintigraphic evidence of CAD in diabetic patients and results were compared with
cardiovascular symptoms and clinical factors.
METHOD AND SUBJECTS: 169 patients with DM (mean age 62 years, 68 males and
101 females) were referred for evaluation of CAD between January 2002 and December
2003. 101 (60%) patients were with chest pain and 68 (40%) were asymptomatic.
Patients underwent exercise (n6) or adenosine stress (n163) SPECT myocardial
perfusion imaging (MPI). Exclusion criteria included history of documented myocardial
infarction, prior revascularization, clinically significant valvular heart disease, left-
bundle branch block on rest ECG. We evaluated symptoms associated with cardiac
problem as well as other clinical and laboratory data to reveal correlation with presence
of CAD. Tomographic images were assessed visually and semi-quantitatively with
C-Equal program.
RESULTS: Myocardial ischemia was detected in 52 (31%) patients. Among them, 41
had 1-vessel disease and 9 had 2-vessel disease. In 52 patients with ischemia, 28/52
(54%) were male and 24/52 (46%) were female. 20/68 (29%) asymptomatic patients
and 32/101 (32%) symptomatic patients had ischemia on MPI. Higher prevalence of
neuropathy, hypertension, higher blood glucose level, HbA1c and CRP was noted in
patients with myocardial ischemia. Serum levels of cholesterol and LDL was not
significantly different between patients with ischemia and with normal MPI findings.
Abnormal MPI findings were not related with gender and age.
CONCLUSION: These results show a high prevalence of abnormal MPI results in
diabetic patients regardless of symptoms. Screening stress MPI in diabetic patients
should be indicated irrespective of symptoms, especially in patients with diabetic
neuropathy, hypertension, higher level of blood glucose, or increased CRP.
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7.37
Assessment of left ventricle perfusion with Tc-99m-MIBI SPECT and RNV in
patients with AMI treated with bone marrow stem cells.
M. Malgorzata Popiel1, S. Grajek1, R. Czepczynski2, P. Breborowicz1, M. Lesiak1, A.
Czyz3, K. Sawinski3, M. Komarnicki3, A. Cieslinski1, J. Sowinski.2 1Institute of
Cardiology, First Department of Cardiology, Poznan, Poland, 2Department of Endoc-
rynology, Poznan, Poland, 3Department of Haematology, Poznan, Poland
Aim of the study: assessement of left ventricle perfusion (LVP) in patients (pts) with
AMI treated with BMSC autotransplantation.
Material and Methods: pts with first anterior wall AMI in whom LAD occlusion was
diagnosed, who were successfuly treated with primary/rescue PCI and who gave
informed consent , were enrolled to the trial. A 5-7 day pts received autologous
transplantation of CD34/AC133 BMSC via infarct related artery (IRA); 14 pts were
treated with BMSC and 7 pts in control group so far, as the trial is ongoing. LVP was
obtained with Tc-99m-MIBI SPECT performed at 3-4 day and after every 3 months.
Radioisotope ventriculography (RNV) was performed at 7 (7-10) day and after 6
months. Semiquantitative Tc-SPECT analysis was based on 5 points scale of tracer
uptake and 16-segmental model of left ventricle which served to calculate perfusion
index (PI; PI[sum of points  16 seg]/16).
Results: age, maximal CPK, sum of ST segment elevation and ST resolution, time
pain-to-needle, TIMI 3 rate, MBG, cTFC after PCI and infarct size approximated by
echo (contractility index) did not differ in both groups. LVP index was better in pts
treated with BMSC, although small number of pts excludes statistical analysis at a
moment [table 1]. RNV results: mean EF at 7 day was 48% in treated group (14 pts) and
45% after 6 months (6 pts so far), and 41% at 7 day (7 pts; NS to 48% in treated group)
and 37% after 6 months in control group (3 pts so far).
Conclusion: perfusion of left ventricle assessed with Tc-99m-MIBI SPECT in pts
treated with BMSC seem to be better than in control group, although further results of
ongoing follow-up are warranted to confirm the data and enable statistical analysis.
Table 1.
pts 4 day 3 mo rest 3 mo dip 6 mo rest 6 mo dip
Treated/n 2,366/14 2,227/12 2,176/12 2,260/7 2,145/7
Control/n 2,482/7 2,68/5 2,712/5 2,895/2 3,194/2
7.38
Concomitant anti-ischemic medication does not affect the prognostic value of a
normal stress myocardial perfusion test.
A. Anto´nio Ferreira, A. Ventosa, V. Gil, J. Calqueiro, S. Lima, C. Aguiar, R. Couto, L.
Raposo, R. Seabra-Gomes. Hospital de Santa Cruz, Cardiology Department, Carnaxide,
Portugal
Background: Whether antianginal medication affects the prognostic value of a stress
myocardial perfusion imaging test remains a controversial issue. Our hypothesis was
that in patients with a normal single photon emission computed tomography (SPECT)
stress test, outcome would be worse in those whose test was performed on anti-ischemic
medication.
Methods: We retrospectively studied 352 consecutive patients with a normal stress
myocardial perfusion SPECT. The study endpoint was time to a major cardiac event
(cardiac death or non-fatal myocardial infarction).
Results: Previously documented coronary artery disease (CAD) was present in 79
patients (22.4%). Stress consisted of an exercise treadmill test in 233 tests (66.2%). At
the time of testing, 71 patients (20.2%) were on beta-blocker therapy, 82 (23.3%) on
calcium channel blockers, and 57 (16.2%) on nitrates. During a median follow-up of 4.8
years (range, 1.4 to 76.1 months), 12 patients (3.4%) suffered a major cardiac event (7
non-fatal myocardial infarctions and 5 cardiac deaths). Time to a major cardiac event
was similar regardless of whether or not the test was performed under the effect of an
anti-ischemic drug: event-free survival at last follow-up was 100% vs. 95.7% for
beta-blockers, 93.9% vs. 97.4% for calcium channel blockers, and 94.6% vs. 96.9% for
nitrates (log rank pns for all comparisons). Independently of the presence or absence
of known CAD, performing the test under any anti-ischemic medication did not
influence outcome, even after adjustment for other variables (age, gender, CAD risk
factors, presence of left bundle branch block, and type of stress).
Conclusion:
A normal stress SPECT performed under anti-ischemic medication remains a strong
indicator of good prognosis.
7.39
Myocardial perfusion imaging in patients with chest pain and nonsignificant
angiographic lesions-correlation to biochemical markers of myocardial injury.
M. Mariana Vasconcelos1, E. Martins2, T. Faria3, A. Oliveira3, M. Garcia2, J. Pereira3,
F. Rocha-Gonc¸alves.2 1Sa˜o Joa˜o Hospital, Cardiology, Porto, Portugal, 2Sa˜o Joa˜o
Hospital, Cardiology, Porto, Portugal, 3Sa˜o Joa˜o Hospital, Nuclear Medicine, Porto,
Portugal
Background: In patients with chest pain and hemodinamycally significant coronary
lesions myocardial perfusion imaging (MPI) has been shown to provide diagnostic
information. Less studies have explore the diagnostic potencial of MPI in patients with
stenosis involving 50% of the coronary lumen, generally considered to have no
hemodynamic significance.
The aim of this study was to evaluate the results of MPI in these patients and to correlate
them to Troponin I (TnI), a sensitive marker of myocardial injury.
Methods: We enrolled 40 patients (19 male), mean age 56.4 years, without a prior
myocardial infarction admitted in our hospital department for chest pain. The initial
assessment included ECG and serum TnI levels (twice with a 6 hour lag). All patients
underwent coronary arteriography (CA) that revealed nonsignificant (50%) angio-
graphic lesions. SPECT MPI was performed with 99m-Tc tetrafosmin 28.8 37.3 days
within CA. Treadmill exercise was used in 13 and pharmacologic stress in 27 patients.
Regarding the results of TnI levels, 2 groups were established: I-Negative TnI (n18);
II-Positive (0,11ng/ml) TnI (n22).
Results: Of the 40 patients, 26 (65%) had a normal SPECT MPI and 14 (35%) had an
abnormal study, including 5 (13%) patients with fixed defects and 9 (22%) patients with
reversible defects. We found no correlation between serum TnI levels and perfusion
defects.
The percentage of normal results was similar in both groups, as shown in table 1. In
patients with negative TnI (group I) we observed a higher incidence of ischemia
(reversible defects).
Conclusion: In patients with chest pain and nonsignificant angiographic lesions there is
a high percentage of abnormal MPI results. The rise of TnI can not predict an abnormal
study in this group of patients.
Table 1.
MPI Group I (n18) Group II (n22)
Normal 61% (11/18) 68% (15/22)
Abnormal 39% (7/18) 32% (7/22)
Fixed Defect 11% (2/18) 18% (4/22)
Reversible Defect 27% (5/18) 14% (3/22)
7.40
Evaluation of perfusion defect and ventricular function in patients with Q wave
and non Q wave myocardial infarction.
C. Caˆndida Lourenc¸o1, C. Roque2, A. Ferrer-Antunes1, M. Ferreira2, L.A. Provideˆncia2,
J. Lima.1 1Coimbra’s University Hospital, Nuclear Medicine, Coimbra, Portugal,
2Coimbra’s University Hospital, Cardiology, Coimbra, Portugal
Aim: The aim of this study was to assess the effect of Q wave and non Q wave
infarction in perfusion defects and ventricular function.
Methods: Sixty nine patients (54 men, 15 women, mean age of 63,412 years) with a previous
myocardial infarction performed a one day stress-rest 99mTc-Tetrafosmin myocardial perfusion
scintigraphy. According to the electrocardiogram (ECG) pattern two groups of patients were
considered: 37 patients with Q wave pattern and 32 patients without the presence of Q waves.
A semi-quantitative analysis of perfusion images was performed using a 17 segment model
based in 3 sections (apical, medial and basal) of the short axis and in a section of the vertical long
axis representing the apex. Overall perfusion scores [stress score (SS), rest score (RS) and
difference score (DS)] were calculated. Rest left ventricular ejection fraction (LVEF), left
ventricular (LV) end systolic volume and LV end diastolic volume were assessed by Cedars
quantitative gated SPECT. A SS greater than 8, a multivessel perfusion abnormality, a LVEF
lower than 45% or a LV end systolic volume higher than 70ml were considered as scintigraphic
high risk factor. Quantitative variables were described as mean sd deviation and ANOVA was
used to compare.
Results: Significant higher SS and RS, lower LVEF and higher LV volumes were
obtained in patients with Q wave ECG pattern There was no significant difference
between the groups in the DS. Ninety two percent of patients with Q wave ECG pattern
had at least one scintigraphic high risk factor; only 34% of patients with non Q wave
pattern had a scintigraphic high risk factor.
Conclusions: Patients with Q wave infarction had significantly more extensive and
severe stress and rest perfusion defects, more depressed LV function and higher LV
volumes. The area of ischemia was similar in both groups.
ANOVA Comparison of groups
Q wave ECG pattern Non Q wave ECG pattern p value
Stress score 19,3  7,4 13,9  6,9 0,0028
Rest score 14,9  7,8 7,87  5,5 0,0001
Difference score 4,3  4,4 5,75  4,2 0,178
LVEF 46,2  15,4 58,6  12,1 0,0087
LV end sistolic volume 94,2  66,3 52  40,3 0,025
LV end diastolic volume 158,5  70,6 115,6  49,7 0,038
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7.41
Diagnosis of CAD at patients with systemic hypertension using myocardial
perfusion imaging SPECT-99m Tc tetrofosmin.
C. Claudia Medrea1, R. Bogdan2, A. Lazar2, S. Mot2, R. Capilneanu.2 1Heart Institute
“N. Stancioiu”, Nuclear Cardiology, Cluj-Napoca, Romania, 2Heart Institute, Cardiol-
ogy Dept., Cluj-Napoca, Romania
Purpose: To compare the accuracy of exercise stress 99m-Tc Tetrofosmin (Myoview) SPECT
for the diagnosis of CAD in patients with and without systemic hypertension (HBP).
Subjects and Methods: 60p(age 54 10 years: 49 males 11 females): 25p with HBP and 35p
without HBP were included in the study.
The MPS SPECT stress test,protocol Bruce 99m-Tc Myoview was performed during
the first day, and the rest MPS SPECT 99m-Tc Myoview was acquired 24 hours after
the stress MPS.
All patients were without previous myocardial infarction.
Significant CAD was defined as 50% luminal diameter stenosis in one or more major
coronary arteries at the coronarography.
LVH criteria at echocardiography: IVS11-15 mm ;PW11-15 mm
Results: * In patients with HBP, the myocardial perfusion abnormalities (MPA) were
detected in 17 of 22p with significant CAD, and 1 of 3p without significant CAD.
* In patients without HBP, MPA were detected in 19 of 27p with significant CAD, and
2 of 8p without significant CAD.
* There was no difference between patients with and without HBP regarding sensitivity,
specificity and accuracy of exercises stress 99m-Tc Myoview SPECT for the diagnosis
of CAD in the two groups, respectively 77% vs. 73% ;
73% vs. 70%; 75% vs. 72% ;pNS
* LVH was detected in 43% of patients. No significant difference was detected between
patients with and without LVH regarding sensitivity, specificity and accuracy of
exercise stress 99m-Tc Myoview SPECT for the diagnosis of CAD.
Conclusion: The exercise stress 99m-Tc Myoview SPECT imaging is a useful method
for the diagnosis and localization of CAD in hypertensive patients, with an accuracy
comparable with that in patients without hypertension.
7.42
Angiotensin-converting enzyme gene polymorphism adds risk for the severity of
coronary atherosclerosis.
V. Vickenty Kozulin, O. Berkovich, T. Ivashchenko, V. Larionova, I. Esipovich, M.
Gordeev, A. Panov, E. Shlyakhto. St. Petersburg, Russian Federation
Purpose: to investigate the relation between the angiotensin-converting enzyme (ACE)
gene polymorphism and severity of coronary atherosclerosis, we analyzed the associ-
ation of genotype with the coronary angiography findings of patients with coronary
artery disease (CAD).
Methods. We determined the ACE genotype in 102 Russian patients with CAD and 112
healthy individuals. The genotype distributions were not different between two groups
(p0.48; Chi-square test). In the first group, coronary angiograms were evaluated by
criteria based on the number of stenotic lesions (60% and more), the priority level of
lesion (proximal or distal) and the type of lesion (diffuse or discrete).
Results. We failed to determined any significant differences between patients with DD
and combined ID or II genotypes based on the priority level of coronary artery lesion
(p0.285). Although the occurence of diffuse coronary artery lesion was higher among
patients with the DD genotype than in those with the ID or II, the differences did not
reach the level of significance. There were significant differences in the number of
stenotic vessels among groups of patients with DD or II and ID genotypes (p0.043)
with prevalence of three vessel lesion in patients with the DD genotype. Having divided
all patients on two groups with single and three vessels lesion we found that patients
with the DD genotype significantly more frequently had three vessels lesion than those
with the ID or II genotypes (48% vs 21,9%, respectively; p0.023).
Conclusions. The results indicate the influence of ACE gene polymorphism on severity
of coronary atherosclerosis, based on this data we may propose that CAD patients with
the DD genotype have more extended coronary atherosclerosis in comparison with
patients having ID or II genotypes.
7.43
MinK gene polymorphism and risk paroxysmal atrial fibrillation in the patients
with sick sinus syndrome.
N. Burova, O. Berkovich1, V. Larionova2 D. Baranov2 V. Timoshin2 E. Shlyakhto1. 1St.
Petersburg, Russian Federation, 2Pavlov State Medical University, St. Petersburg,
Russian Federation, State Pediatric Medical Academy, St. Petersburg, Russian Feder-
ation.
Aim. To study the association of the MinK gene polymorphism with risk of paroxysmal
atrial fibrillation (AF) in the patients with sick sinus syndrome (SSS).
Material and methods: Two hundred eighteen patients with SSS were examined:
The electrocardiography, Holter monitoring exercise test, electrophysiiological study
with medical autonomic denervation, pharmacological tests, and echocardiography
were performed at the background of the sinus rhythm. The patients were followed up
for 5 years or more. According to the clinical course of the disease, all patients were
divided into 2 groups, as follows:
1. Group 1, 108 patients with SSS without paroxysmal AF (43 men, 65 women, mean
age 68  1 year).
2. Group II, 110 patients with SSS and paroxysmal AF (34 men, 76 women, mean age
72  1 year). The MinK gene genotypes (38G/38G, 38S/38S, 38G/38S) identification
was carried out with use of polymerase chain reaction with subsequent restriction
analysis. Fisher’s Exact Test was used for the statistical analysis.
Results: The MinK 38G allele was found more ferquently than the MinK 38S allele in
all groups (38G 1  51.46%; 38G II  64.55%). The odds ratio (OR) for paroxysmal
AF in patients with 1 MinK 38G was 1,79 (95% Cl 1,22 — 2,63), with compared in
patients with MinK 38S allele. In the patients of group I and II, the 38G/38S genotype
of MinK gene was found the most frequently (table 1). The OR for paroxysmal AF in
patients with 38G/38G genotype of MinK gene was 2,25 (95% Cl 1,24 — 4,07) when
compared with patients with others MinK genotypes (38S/38S and 38G/38S).
Conclusion: The association between the MinK 38G allele ans paroxysmal atrial
fibrillation in patients with sick sinus syndrome was found. An increased risk of
paroxysmal atrial fibrillation in patients wit h 38G/38G genotype of MinK gene was
shown.
Table 1.
Group 38G/38G (1) 38S/38S (2) 38G/38S (3) p (1/2) p (1/3) p (2/3)
I 24 (2.22%) 23 (21.3%) 61 (56.48%) 0.869 0.001 0.001
II 43 (39.09%) 1‘1 (10%) 56 (50.91%) 0.001 0.078 0.001
7.44
The use of phenotype characteristics in mutation analysis of families with long QT
syndrome.
S. Chuprova, M. Shkolnikova1, E. Zaklyazminskaya2, A. Poliakov2. Center of Chil-
dren’s Arrhythmias, Moscow, Russian Federation1 Center of Children’s Arrhythmias,
Moscow, Russian Federaion2, Research Center of Medical Genetics, Moscow, Russian
Federaion
The long QT syndrome (LQTS) is a cardiac disorder characterized by a prolonged QT
interval and life-threatening tachyarrhythmias, which may give rise to recurrent syncope
or sudden cardiac death. 70 unrelated Russian families were clinically evaluated using
family and medical histories (including age at the first syncope and symptom related
triggers of proands and their relatives), ECGs, Holter recordings with the heart rate
variability (HRV), exercise test (treadmill), the efficacy of beta-blocking drugs and
Na channel blockers. We have tested all of the patients for mutation in 5 genes:
KCNQ1 (exons 2,4,5,6,7,14), KCNH2 (exons 2,6,7,10), SCN5A (exon 17), KCNE1 and
KCNE2 using PCR-SSCP analysis and then direct sequensing. Mutations were founded
in 35 families (50%): KCNQ1 in 26 families, KCNH2 in 6 families, SCN5A in 1 family
and KCNE1 in 1 family. In one family (one patients) were founded mutations in 2 genes
(KCNH2-W585C and KCNE1-V1071). Using ECG features exclusively 66% of the
genotyped cases were precicted correctly (patients with KCNH2 mutations have more
high per cent). Using ECG and other phenotype-genotype correlations 91% of all (35
families) genotyped cases were predicted correctly. Patients with KCNQ1 mutations
have an early age at the first syncope, but not patients with KCNH2 mutations (6,13,6
and 13,67,4 years respectively, P0.05). In patients with KCNH2 muations arrhyth-
mogenic syncope often occurred in association with emotional and especially acoustic
stimuli, in patients with KCNQ1 mutations with exercises, the combination of exercises
and emotional stress and especially swimming. The QTc was significantly prolonged
during exercise in patients with KCNQ1 mutations (509,653,4 ms and 545,246,1 ms
respectively, P0,05) but not in patients with KCNH2 mutations. Some HRV
parameters (time-domain) were differences between patients with KCNQ1 and KCNH2
mutations. In patients with KCNQ1 mutatiosn beta-blockers were effective in more high
doses then in patients with KCNH2 mutations. Conclusions: Using ECG and other
phenotype-genotype correlations 91% of all genotyped cases were predicted correctly.
The prediction of most eligible gene may be based on phenotype-genotype correlations
and must determine screening strategies in families with LQTS.
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7.45
Evaluation of stem cell therapy in patients with acute myocardium infarction using
radionuclide methods.
S. Svetlana Sazonova, V.I. Chernov. Inst. of Cardiology, Nuclear Medecine, Tomsk,
Russian Federation
Aim. The aim was to assess therapeutic effect of stem cells in patients with acute
myocardial infarction using radionuclide methods.
Methods and patients. We examined 10 pts with acute myocardial infarction (MI) who
were treated by intracoronary infusion of autologous stem cell (ASC) into the
infarct-related artery. To track transplanted ASC in myocardium we labeled part of
them using 40-60 mCi of 99mOn-HMPAO. Whole-body scans were performed at
30min, 2h and 24h post injection, following by calculation of radioactivity percentage
in the heart to total radioactivity.
In order to evaluate long-term effect of ASC transplantation on myocardium we also
performed SPECT with 199Tl-chloride on the terms of 2 weeks and 6 months after ASC
transplantation in the same group. The presence, character and size of perfusion defects
were estimated.
Results. As a result of our study in myocardium of examined patients at 30min
remained 4.71.2% of labeled ASC, at 2h-2.50.4% and 24h-1.90.2% of total
99mOn-HMPAO-ASC. SPECT with 199Tl-chloride showed that the average size of
stable perfusion defects at 2 weeks after ASC transplantation was 28,763,57% and
after 6 month decreased up to 21,693,58% (p0.01).
In the same time we observed improvement of clinical signs of the disease on the term
of 6 month, including changes of NYHA functional class from 1.40.5 to 1.20.4 and
of left ventricle ejection fraction-from 44.211.5% to 50.55.0%.
Conclusion. Our results showed that the largest number of transplanted ASC remains
in the myocardium of patients with MI. It was also confirmed that such kind of therapy
provides positive effect on the myocardium perfusion. However, it is not still clear
either perfusion improves due to direct action of transplanted cells or as a result of their
mediate influence on adjoining tissues.
7.46
Gated SPECT abnormalities and risk factors in patients with symptomatic
intracranial atherosclerotic stenosis.
G. Romero-Farina, JF. Arenillas, J. Candell-Riera, S. Santiago Aguade´-Bruix, G. De
Leon, CA. Molina, P. Chacon, J. Montaner, A. Rovira, J. Alvarez-Sabin. Vall d’Hebron,
Nuclear Medicine, Barcelona, Spain
Aim of the study. The relationship between intracranial large-artery atherosclerosis
(ILA) and coronary artery disease (CAD) remains unsettled. We aimed to investigate
the prevalence of myocardial ischemia in symptomatic ILA-patients and to detect the
factors that are associated with its presence.
Methods. Forty-nine first-ever patients with symptomatic ILA (mean age: 65 8 years,
14 female) without history of CAD underwent a maximal-exercise 99mTc-MIBI
myocardial gated-SPECT (one day stress-rest study). Thirty-one patients had medical
history of hypertension, 35 hypercholesterolemia, 24 were cigarette smokers and 21
diabetes mellitus. Thirty-one patients presented an ischemic stroke and 18 a transient
ischemic attack. In the cranial magnetic resonance imaging (angiographic sequences)
130 intracranial stenosis were observed. Lipoprotein (a) (Lp(a)), C-reactive protein, and
homocysteine (Hcy) levels were determined previous to SPECT. Twenty-one patients
had 3 risk factors (RF), 18 two, and six had one. Twenty-eight patients performed a
symptom-limited exercise test (ET), in 14 patients dipyridamol was administered during
submaximal exercise, and seven underwent dipyridamol stress test.
Results. Gated-SPECT showed reversible myocardial perfusion defects in 21 (43%)
patients and fixed defects in three patients. Eleven patients developed a horizontal
download of the ST segment more than 1 mm during the exercise test and two presented
angina. Univariate analysis showed that males (p0.05), diabetes (p0.02), 2
vascular risk factors (p0.006), asymptomatic cervical internal carotid artery (ICA)
lesions (p0.04), multiple intracranial stenoses (p0.03), intracranial ICA stenosis
(p0.02), high Hcy levels (p0.01) and high Lp(a) levels (p0.04), were significantly
associated with myocardial ischemic defects. A multiple logistic regression model
identified 2 risk factors (OR 5.85, 95% CI 1.37-24.96, p0.016), intracranial ICA
stenosis (OR 5.51, 1.09-27.7, p0.03) and high Hcy (OR 7.73, 1.43-41.85, p0.017)
as independent markers of myocardial ischemia.
Conclusions. Patients with symptomatic ILA stenosis have a high prevalence of
myocardial ischemia in the gated SPECT. The presence of more than two risk factors,
high Lp(a) levels, high Hcy levels, and location of the symptomatic stenosis in
intracranial vertebro-basilar arteries could characterize patients as higher risk of CAD.
7.47
Caffeine decreases coronary flow reserve in CAD patients.
M. Mehdi Namdar1, PT. Siegrist2, R. Grathwohl2, R. Delaloye2, P. Koepfli2, CA.
Wyss2, PA. Kaufmann.2 1Zurich, Switzerland, 2Cardiovascular Centre, Nuclear Cardi-
ology University Hospital, Zurich, Switzerland
Purpose: Caffeine competitively antagonizes adenosine-induced hyperemic myocardial
blood flow (MBF). We studied the acute impact of caffeine on exercise-induced
hyperemic MBF response in coronary artery disease (CAD) patients.
Methods: 15O-labelled H2O and Positron Emission Tomography (PET) was used to
measure regional MBF in 9 patients with CAD (mean age 58y  9) at rest and using
supine bicycle exercise stress (mean workload 98% of predicted) before and 50 minutes
after oral ingestion of caffeine (200mg). Hyperemic MBF of stenotic segments was
expressed as percentage of hyperemic MBF in remote segments representing an index
of relative flow reserve.
Results: Caffeine levels were zero at baseline in all subjects and increased to 18 
9mmo/l fifty minutes after caffeine intake. Neither rate pressure product (rest and
exercise) nor resting MBF were affected by caffeine. By contrast, hyperemic MBF was
significantly decreased in remote (2.60.9 to 2.00.7 ml/min/g, 23%; p0.05) and
even more pronounced in stenotic segments (2.40.6 to 1.60.72 ml/min/g 33%,
p0.005). Relative flow reserve decreased from 92% to 80%.
Conclusions: Caffeine consumption at an equivalent dose of two cups of coffee
severely decreases hyperemic MBF response to exercise in patients with CAD. The
decrease in relative flow reserve indicates that the adverse effect of caffeine is
specifically pronounced in the stenotic segments, where poststenotic adenosine-
mediated dilative compensatory mechanisms of the microcirculation seem to be
particularly prone to the antagonistic effect of caffeine.
7.48
Impact of myocardial perfusion scanning with 13N-ammonia PET and revascu-
larization on long-term prognosis in patients with coronary artery disease.
N. Bartenstein1, J. Hellermann2, P. T. Patrick Siegrist1, M. Namdar1, P. Koepfli1, C.
Pollack1, U. Schurr3, P.A. Kaufmann.1 1University Hospital Zurich, Nuclear Cardiol-
ogy, Zurich, Switzerland, 2University Hospital Zurich, Cardiovascular Center, Zurich,
Switzerland, 3University Hospital Zurich, Cardiac Surgery, Cardiovascular Center,
Zurich, Switzerland
Background: Very limited data exist on the long-term prognostic impact of PET
myocardial perfusion scan with 13N-ammonia.
Aim: To assess the impact of myocardial perfusion scanning with PET and revascu-
larization (revasc) on long-term prognosis in patients with coronary artery disease
(CAD).
Methods: The baseline characteristics and the follow up (f/u) of 68 consecutive patients
(age 5910 years) with ischemic LVD who underwent FDG and NH3 PET scan for
assessment of hibernating myocardium (NH3/FDG mismatch) was assessed. Patients
were assigned according to the PET findings into hibernating and no hibernating.
Results: see table 1
Conclusion: Our results demonstrate a strong association between ischemia as detected
by PET and improved survival after revascularization in ischemic patients. This
association is not confined to short term follow up but is even more pronounced in the
5-year mortality. PET seems to predict correctly those who benefit most from
revascularization procedure.
Table 1.
Ischemia Ischemia No Ischemia No Ischemia
Revasc No Revasc Revasc No Revasc
n 10 13 13 32
gender, male 87% 82% 83% 88%
mean f/u, years 6.52.1 4.73.1 5.32.8 5.13.3
first year mortality 10% 15% 15% 22%
5-year mortality 20% 54% 46% 41%
Survivors, end of f/u 70% 46% 45% 55%
T
U
E
S
D
A
Y
M
A
Y
10
T
U
E
S
D
A
Y
M
A
Y
10
S52 Abstracts Journal of Nuclear Cardiology
Tuesday, May 10, 2005 March/April 2005
7.49
Normal myocardial perfusion SPECT in patients with relevant coronary stenoses
in whom does it occur?
M.J. Michael Zellweger1, P.C. Burger1, J. Mueller-Brand2, M.E. Pfisterer.1 1University
Hospital, Cardiology Department, Basel, Switzerland, 2Basel University Hospital,
Nuclear Medicine Dept., Basel, Switzerland
Background: Myocardial perfusion SPECT (MPS) provides excellent diagnostic and
prognostic information in the evaluation of coronary artery disease. However, normal
MPS sometimes occur despite relevant stenoses on coronary angiograms (cath). Little
is known about predictors of relevant stenoses (RS) in patients with normal MPS. The
aim of this study, therefore, was to evaluate predictors of RS in patients with normal
MPS.
Methods: A consecutive series of 182 patients with normal MPS referred for cath was
evaluated. All patients underwent rest Tl-201/stress Tc-99m sestamibi MPS. MPS were
interpreted using a 20 segments’ model and a scale of 0 to 4. Summed scores were
calculated by adding the 20 SPECT segment scores. Summed rest (SRS), stress (SSS)
and difference scores (SDS) were derived. A normal MPS was defined by SSS  4 and
SDS  2. A stenosis of  75% assessed visually by cath was considered relevant.
Results: Out of 182 patients (36% female, mean age 62.510.3y) with normal MPS,
70 (38%) had RS on cath. In 80% of these patients, only distal coronary segments were
diseased. Patients with RS were older (6611 vs 6010y; p0.001), more often
reported angina during stress testing (31% vs 17%; p0.029), reached lower peak watts
(10850 vs 12654; p0.038) and peak heart rates (12229 vs 13630; p0.003),
and more often had transient ischemic dilation (TID) (7% vs 1%; p0.029) than
patients without RS. Of note, there was no difference of antiischemic medication during
stress testing between the 2 groups. Importantly, patients with triple vessel disease more
frequently demonstrated TID than patients with 0,1, or 2-vessel disease, 10% and 2%,
respectively; p0.031). In the multivariate logistic regression analysis only age (OR
1.05, 95% CI 1.02-1.09; p0.004) and angina during stress testing (OR 2.15, 95% CI
1.03-4.48;p0.041) were significant and TID borderline significant (0.096) predictors
of RS.
Conclusions: In a population referred for cath, 38% of patients with normal MPS had
RS on cath. In 20% of these patients, i.e. in only 8% of the overall patient population,
RS were located in proximal coronary segments. Furthermore, patients with triple vessel
disease more often demonstrated TID than patients without triple vessel disease. Thus,
elderly patients with angina during stress testing and patients who eventually demon-
strate TID tend to have RS even when myocardial perfusion was normal.
7.50
Significance of ST elevation on stress myocardial perfusion scans (MPI) in women.
L. Leonie Gordon1, A. Epps2, S. Chiarameda.2 1Medical University of South Carolina,
Nuclear Medicine, Charleston, SC, United States, 2Medical University of South
Carolina, Cardiology, Charleston, SC, United States
Introduction: Both positive and negative treadmill exercise tests in women have a
relatively low predictive value for significant coronary artery disease.The prognostic
value of stress induced ST-segment depression in women has been reviewed; however
there is limited data on the significance of ST-segment elevation.Furthermore there is
evidence that patients with ST -segment elevation on stress ECG coupled with
reversible perfusion defects on MPI are likely to benefit from cardiac intervention. In
this study, we analyzed the occurrence and significance of ST-segment elevation in a
large group of women undergoing stress MPI.
Methods: We did a retrospective analysis on stress MPI tests on 4,357 women from
October 1997 to September 2003 performed for routine clinical indications. Stress tests
were done with exercise(Bruce or modified Bruce) or pharmacologically with either
adenosine, dipyridamole or dobutamine infusion. MPI was performed with Thallium-
201 and/or Technetium-99m sestamibi or tetrofosmin SPECT. Stress ECGs were
analyzed and ST-segment elevation was reported if there was at least 1mm of elevation
from baseline in at least two contiguous leads. Myocardial defects were reported
according to standard ASNC criteria. We then reviewed how many of these women
underwent left heart catheterization and the significance of these findings. Significant
flow limiting coronary artery disease was defined as greater than a 70% stenosis of the
coronary lumen diameter.
Results: In review of stress ECG changes ST-segment elevation was identified in 74 out of
4,357 females (1.7%). MPI analysis demonstrated that 16 out of these 74 women (22%) had
reversible perfusion defects. Of these 16 women with reversible perfusion defects, 4
underwent dobutamine, 4 adenosine or dipyridamole and 8 underwent exercise stress. 11 out
of these 16 female patients (69%) underwent left heart catheterization and all 11 had critical
flow limiting lesions amenable to intervention or surgery.
Conclusions: We found that ST-segment elevation on stress ECG is less prevalent in
females. Furthermore ST-segment elevation on stress ECG is less likely in females to
be associated with a reversible perfusion defect on MPI (22%). However, most
importantly those females with ST-segment elevation and reversible perfusion defects
on stress MPI are as likely if not more likely to undergo left heart catheterization than
males ; and these females are also as likely if not more likely to have significant flow
limiting coronary lesions amenable to intervention or surgery.
7.51
Incremental prognostic value of exercise capacity in risk stratification of patients
with left bundle branch block using ECG-gated Tc-99m sestamibi stress myocar-
dial perfusion imaging.
S. Sachin Navare1, A. Ahlberg2, G. Cyr2, D. Katten2, A. Ausef2, G. Heller.2 1Hartford
Hospital, Hartford, CT, United States, 2Hartford Hospital, Nuclear Cardiology, Hart-
ford, CT, United States
Background: Pharmacologic stress myocardial perfusion imaging (MPI) is preferred over
exercise stress MPI for the diagnosis of coronary artery disease in patients with LBBB. However,
there are no data comparing the two modalities for evaluating prognosis.
Methods: We identified 459 consecutive patients with preexisting LBBB who underwent either
exercise stress (n  240) or pharmacologic stress (n  219) MPI based on their ability to
exercise. Using a 17 segment model and a 5-point scoring system, perfusion was classified as
normal (summed stress score [SSS]  3) and abnormal (SSS  3) and LV function was
classified as normal ( 50%) or impaired (50%). Functional capacity, measured in metabolic
equivalents (METS), was determined for patients undergoing exercise stress. Follow-up was
complete in 92% of patients (mean 27.5 months).
Results: On follow up, cardiac event (myocardial infarction, cardiac death, unstable
angina and revascularization) rates were similar in the exercise and pharmacologic
groups (overall :7.0 % vs 7.1%, pns ; with normal perfusion and function: 2.5% vs
6.5%, pns; and with abnormal perfusion or function: 9.7% vs 13.7%, pns). However
patients whose exercise capacity was  8 METS had significantly better survival than
patients with exercise capacity  8 METS and those undergoing vasodilator stress with
either normal or abnormal perfusion and function. (see picture)
Conclusion: Exercise and pharmacologic stress MPI are equivalent in their ability to
risk stratify patients with LBBB. Assessment of functional capacity adds incremental
prognostic value over MPI and hence exercise stress MPI should be the preferred
modality for risk stratification of patients with LBBB who are able to exercise.
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7.52
ST depression during pharmacological stress testing in patients with left ventricular
hypertrophy predicts extensive coronary artery disease.
B. Bruce Darrow, M. Henzlova. Mount Sinai School of Medicine, Medicine/Cardiology, New
York, NY, United States
For patients with left ventricular hypertrophy (LVH), ST depression on ECG during exercise
stress testing has reduced specificity for the detection of coronary artery disease (CAD). We
hypothesize that during stress testing with coronary vasodilators, ST depression is a significant
indicator of CAD even if LVH is present.
Methods: We identified 161 patients with suspected CAD who had 1.0 mm ST depression
during adenosine or dipyridamole infusion for stress tests performed between January 1, 2000
and December 31, 2003. SPECT imaging was performed in 114 patients (112 Tc-99m and 2
Tl-201) and PET imaging (Rb-82) in 47 patients. Using standard ECG criteria, 40 patients had
LVH (Group 1, LVH/ST) and 121 patients did not (Group 2, LVH-/ST). Patients were
excluded for significant LV outflow obstruction, digoxin use, LBBB, paced rhythm, or
pre-excitation. A control group included all patients with suspected CAD who had LVH but no
ST depression during pharmacological stress (Group 3, LVH/ST-, n482). We recorded the
incidence of perfusion defects as well as results of 136 patients who underwent subsequent
coronary angiography (mean follow-up time 836  29 days).
Results: The groups did not differ in age or gender. As shown in Table 1, the LVH/ST and
LVH-/ST groups had significantly higher rates of perfusion defects than LVH/ST- patients.
Among those subsequently catheterized, the incidence of CAD (stenosis 50%), as well as
multivessel and/or left main disease, was also significantly increased in both the LVH/ST
and LVH-/ST groups. Similar results were observed when only catheterization data from
patients with perfusion defects were analyzed.
Conclusions: ST depression during pharmacological testing is a predictor of extensive CAD
not only for patients without LVH but also for patients with LVH on rest ECG.
Table 1.
LVH/ST
Group 1 n40
LVH-/ST
Group 2 n121
LVH/ST-
Group 3 n482
p
(Group 1 vs 3)
p
(Group 1 vs 2)
Any perfusion defect 28 (70%) 87 (72%) 204 (42%) 0.0007 NS
Any reversible defect 26 (64%) 83 (69%) 145 (30%) 0.0001 NS
Multivessel defects 13 (33%) 37 (31%) 62 (13%) 0.0007 NS
Coronary angiography
performed (n136) 13 (32%) 40 (33%) 83 (17%) 0.02 NS
Angiographic CAD 12/13 (92%) 37/40 (93%) 37/83 (45%) 0.001 NS
Multivessel and/or
left main CAD 9/13 (69%) 33/40 (83%) 21/83 (25%) 0.001 NS
7.53
Risk assessment with MPI prior to non-cardiac surgery: A real world experience.
G.S. Gregory Thomas1, T.K. Ip2, R.C. Thompson3, D.B. Kramer4, D.L. Rice5, J.J. Thomas6,
M.I. Miyamoto.7 1Mission Internal Medical Group, Mission Viejo, CA, United States, 2Mission Internal
Medical Group, Mission Viejo, CA, United States, 3Cardiovascular Consultants, Kansas City, MO, United
States, 4Harvard Medical School, Boston, MA, United States, 5MIssion Internal Medical Group, Mission Viejo,
CA, United States, 6Yale University, New Haven, CT, United States, 7Unversity of California, San Diego, CA,
United States
Background: ACC/AHA guidelines support the role of stress myocardial perfusion imaging (MPI),
prior to specific non-cardiac operations in patients with major and intermediate risk predictors.
Scant literature exists, however, as to the current clinical use of MPI prior to non-cardiac surgery.
Methods: A prospective evaluation of 5458 patients undergoing stress MPI in a
community based outpatient US laboratory.
Results: MPI was performed prior to non-cardiac surgery in 291 patients (5.3%, “Preop”) vs. the
remainder (“Nonop”). Preop patients were older, 67.9 11.9 yrs vs. 64.6 16.8 (p.004) and more
frequently underwent adenosine stress, 70% vs. 38% (p.0001). Exercise stress was performed in 26%
and 60% and dobutamine in 4% and 3% of the Preop vs. Nonop groups, respectively. Preop and Nonop
groups did not differ according to gender (41% women vs. 35% pNS) or post-stress EF (59.8% vs.
59.2%). Table 1 describes the type of non-cardiac surgery performed.
Conclusion: While substantial evidence supports the use of MPI prior to vascular surgery, MPI is much
more commonly used prior to other operations, most notably orthopedic, representing 48% of the
population, and prior to a relatively new procedure, gastric bypass (6%). These findings suggest the need
for studies of the relative utility of MPI prior to these procedures. While MPI is not expected to be
indicated prior to low risk surgery, these patients represented 6% of the population.
Types of non-cardiac surgery
HIGH RISK
Aortic & major vascular 5%
INTERMEDIATE RISK
Carotid 1%
Head & Neck 2%
Abdomen & chest (gastric bypass in 6%) 22%
Orthopedic 48%
Prostate & Bladder 5%
LOW RISK
Endoscopic & superficial 1%
Eye 4%
Breast 1%
Stratified by ACC/AHA cardiac risk category
7.54
Left ventricular dysfunction after vasodilator stress is more accurate than
perfusion for diagnosis of coronary artery disease.
RS. Regina Druz1, KJ. Nichols2, OO. Akinboboye1, N. Reichek.1 1St. Francis Hospital,
Cardiac Imaging Research Group, Roslyn, NY, United States, 2Long Island Jewish
Medical Center, Department of Nuclear Medicine, New Hyde Park, NY, United States
Background: Three-vessel coronary disease (3VD) is difficult to detect by perfusion
imaging due to balanced ischemia. We hypothesized that post-stress left ventricular
(LV) dysfunction should more accurately identify 3VD.
Methods: 86 pts. (7412yrs; 58 male) with rest Tl-201/adenosine Tc-99m sestamibi
scans were identified: 43 with known/suspected coronary stenoses with  1 segmental
reversible defect, and 43 age- and sex-matched controls with no coronary disease and
normal LV perfusion and function. Perfusion was based on a 20-segment/5-point
summed difference score (SDS), with a cut-off  8 for extensive defects. Segments
with no tracer uptake were excluded to lessen partial volume effects. LV ejection
fraction (EF) and end-systolic volume (ESV) were quantified at rest and 60 min
post-adenosine by QGS (Cedars-Sinai Medical Center, Los Angeles, CA). LV dysfunc-
tion post-adenosine was defined as EF decrease  12% ( 2 SD of the mean EF
decrease in controls: 0.96.0%). LV dilation ratio was measured by ESV adenosine:
rest. Angiography was performed in 36/43 pts with segmental defects, and 15/36 pts had
3VD. McNemars test (p0.05) was used to compare SDS 8 vs. EF decrease12%
for tests sensitivity, specificity and accuracy for 3VD.
Results: See Table.
Conclusion: LV dysfunction manifested as stunning, with decrease in LV EF and LV
dilation in patients with extensive reversible defects, especially those with angina. A
decrease in EF was more specific and accurate for 3VD than perfusion. Thus, gated rest
and stress studies had improved diagnostic yield over perfusion for 3VD.
Table
EFdecrease
12% Angina SDS
ESV
adenosine:rest
EF12%
for 3 VD SDS 8 for 3VD
(); n33 9% 65 1.30.2 Sens/Spec 87%/82%* Sens/Spec
87%/48%
(); n10 44%* 105* 1.70.3* Accuracy 83%* Accuracy 62%
*p  0.05
7.55
Prognostic value of heart rate response in patients with atrial fibrillation under-
going gated SPECT Tc-99m sestamibi exercise stress testing.
E. Ernest Podrasky, M. Henzlova. Mount Sinai Medical Center, Cardiology, New York,
NY, United States
OBJECTIVE: Pharmacologic control of ventricular rate with anticoagulation is a
well-established management strategy for atrial fibrillation (AF). However, the clinical
significance of heart rate control during exercise testing is unclear. We sought to
determine the prognostic value of heart rate control, with regard to mortality and
hospitalization for cardiovascular causes, in patients undergoing exercise stress testing
done in conjunction with myocardial perfusion imaging.
METHODS: We reviewed a total of 16,109 consecutive patients who underwent
myocardial perfusion imaging between January 2000 and December 2003. Of those,
130 had AF and had undergone exercise testing. A heart rate index (HRI  maximum
heart rate/# METS achieved) was calculated for each patient to adjust for level of
exercise. Patients were divided into a rate-controlled group (HRI  or  10; n  56)
and a rate-uncontrolled group (HRI  10; n  74). Mortality data was obtained from
the National Death Index, and hospitalizations were determined by review of hospital
records. Presence of CAD and LVEF were assessed by gated SPECT Tc-99m sestamibi
myocardial perfusion imaging. Mean follow-up was 29  10 months.
RESULTS: There was no difference between the rate-controlled and uncontrolled
groups with respect to age (mean  70.3 vs. 72.2 years), sex, baseline heart rate
(mean  72 vs. 75), number of medications used (mean  1.3 vs. 1.2), LVEF (mean 
58% vs. 57%), or presence of CAD (73.2% vs. 64.9%), respectively (P  0.05 for all
subgroups). Exercise capacity was significantly greater in the rate-controlled group
(mean 8.3 METS vs. 4.6 METS for the rate-uncontrolled group, P 0.00001). There
was 1 death (1.8%) in the rate-controlled group vs. 5 deaths (6.8%) in the rate-
uncontrolled group (P  0.18). Twelve patients (21.4%) in the rate-controlled group
were hospitalized for cardiovascular causes, vs. 24 patients (32.4%) in the rate-
uncontrolled group (P  0.12). For the combined endpoint of death or hospitalization,
there were significantly fewer events in the rate-controlled group than in the uncon-
trolled group (21.4% vs. 37.8%, P  0.03).
CONCLUSION: Heart-rate control during exercise testing is associated with better
exercise capacity and improved cardiovascular outcomes in patients with AF. The heart
rate index measured during exercise stress testing may be a useful tool for assessing the
adequacy of ventricular rate control.
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7.56
Incremental prognostic power of adenosine SPECT myocardial perfusion imaging
in high risk patients for coronary artery disease: a comparison with cardiac
catheterization data.
RT. Robert Tuttle1, LS. Linda Shaw1, MWH. Michael Hanson2, S. Salvador Borges-
Neto.3 1Duke Clinical Research Institute, Medicine, Durham, NC, United States, 2Duke
University, Nuclear Medicine Dept., Durham, NC, United States, 3Duke University
Medical Center, Radiology/Nuclear Medicine, Durham, NC, United States
Background: Adenosine SPECT myocardial perfusion imaging provides prognostic
information in patients with suspected coronary artery disease (CAD); limited data
however, are available on the incremental prognostic value of this modality in high risk
patients with angiographically documented coronary artery anatomy. Therefore, the
purpose of this investigation was 1) to evaluate the prognostic value of adenosine
SPECT myocardial perfusion imaging for predicting adverse events in a high risk
patient population with coronary angiography and 2) to compare the prognostic value
of adenosine SPECT with that of cardiac catheterization data. Methods: We studied a
total of 662 patients who underwent cardiac catheterization and adenosine SPECT
imaging. The mean follow up was 2.3 years for cardiovascular death(CVD). Using Cox
proportional hazards regression models, we 1) examined the relationship between
adenosine SPECT and CVD after adjusting for a previously-validated baseline clinical
index and, 2) compared the prognostic value of adenosine SPECT with that of
angiographic data (number of diseased vessels). Results: During the follow-up period,
86 patients died from cardiovascular causes. After adjusting for clinical information,
adenosine SPECT provided significant incremental prognostic information: incremental
Chi-sq  6.27; p  0.012 for CVD. Furthermore, adenosine SPECT provided
prognostic information above that provided by clinical and cardiac catheterization
combined: incremental Chi-sq  4.5; p  0.03 for CVD. Conclusions: Adenosine
SPECT imaging adds significant incremental prognostic information to clinical and
cardiac catheterization data for the prediction of cardiovascular death in high-risk
patients with angiographically documented CAD. Furthermore, adenosine SPECT
imaging can further risk-stratify patients even after considering clinical and cardiac
catheterization data.
7.57
The utility of myocardial perfusion imaging and duke treadmill score in predicting
outcome in Hispanic versus Caucasian women.
J. Justin Lundbye, S. Werden, F. Kazi, A. Whalen, G.L. Noble, D. Katten, D.
O’Sullivan, A. Ahlberg, W.E. Boden, G.V. Heller. Hartford Hospital, Cardiology,
Hartford, CT, United States
Background: The utility of SPECT myocardial perfusion imaging (MPI) and Duke
Treadmill Score (DTS) has been well characterized in the general population. These
testing methods however, have not been evaluated in women of different ethnicities.
The purpose of this study was to determine whether DTS and MPI differ in predicting
outcome in Caucasian versus Hispanic women.
Methods: Women with intermediate or high pretest likelihood of CAD who underwent
ETT/Rest Tc99 Sestamibi MPI (n1,177) were categorized as low, moderate or high
risk DTS. MPI was categorized as normal or abnormal. Mean follow-up was 2.38 1.2
years for all-cause mortality, revascularization (60 days), and non-fatal myocardial
infarction was evaluated by ethnicity.
Results: Caucasian comprised 71.5% and Hispanics 28.5% of the population studied.
There were no significant differences between the groups with respect to CAD risk
factors. Women with a low risk DTS (5) had an overall annual event rate of 1.70%
(Caucasian 1.76 %, Hispanic 1.13%, p0.79). Similarly, moderate and high risk DTS
had an annual event rate of 4.38% (White 4.29% Minority 4.83, p0.74), 13.86%
(White 13.15% Minority 21.01%, p1.0), respectively. A similar observation was seen
in Summed Stress Score (SSS). Women with a normal SSS (4) had an overall annual
event rate of 2.39% (White 2.35% Minority 2.44%, p0.88) while an abnormal SSS
(4) had an overall annual event rate of 11.76% (White 15.13% Minority 8.40%,
p0.10). (Chart)
Conclusion: Outcome in Hispanics versus Caucasians does not differ when comparing
Duke Treadmill Score and Myocardial Perfusion Imaging.
Outcome in Women
7.58
Stress Tc-99m sestamibi ECG-Gated SPECT is effective for risk stratification of
patients with left ventricular systolic dysfunction and suspected CAD.
A. Amir Ausef, A. W. Ahlberg, D. O’Sullivan, P.G. Danias, G.I. Papaioannou, I. A. Leka, W. E.
Boden, G. V. Heller. Hartford Hospital, Cardiology, Hartford, CT, United States
Background: Stress Tc-99m sestamibi ECG-gated SPECT is highly sensitive for the
detection of coronary artery disease (CAD) in patients with left ventricular (LV) systolic
dysfunction. However, the value for risk stratification of this population is unknown.
Methods: We identified 164 consecutive patients without known CAD and LV ejection
fraction (EF)  40% (mean 30  7) on stress ECG-gated SPECT who underwent
cardiac catheterization (CC) within 90 days (mean 12  16). Significant CAD by CC
was defined as a 50% diameter stenosis. Using a 17-segment model, the following
criteria were used for detection of significant CAD by ECG-gated SPECT: summed
stress score (SSS) 8 or summed difference score (SDS) 0 or regional wall motion
variance (RWMV) 0.114. Patients were followed for myocardial infarction (MI) or
cardiac death (CD).
Results: Of the 128 patients who fulfilled criteria for CAD by ECG-gated SPECT, 92 (71.9%)
had significant CAD by CC. Conversely, 30 of the 36 (83.3%) patients who did not fulfill criteria
for CAD by ECG-gated SPECT did not have significant CAD by CC. Follow-up was complete
in 156 (95.1%) patients (mean 33.2  24.4 months). Of these, 24 (15.4%) had MI or CD of
which 21 (87.5%) fulfilled criteria for CAD by ECG-gated SPECT. Each of the patients with MI
(n 15) had a SSS8 or SDS0 (mean 13.8 4.8 and 5.3 3.9, respectively). Patients with
a SSS 8 and SDS 0 and RWMV0.114 (CAD -) had better cardiac event-free survival than
those with a SSS 8 or SDS 0 or RWMV 0.114 (CAD ).
Conclusion: ECG-gated SPECT is effective in risk stratification of patients with LV
systolic dysfunction and suspected CAD. These findings support a role for this
noninvasive technique as an initial evaluation in this population.
Kaplan- Meier survival curve
7.59
Prognostic value of myocardial stunning as detected by gated SPECT during a
cardiac perfusion stress test.
M. Mario Beretta, S. Vin˜as, A. Gonzalez, I. Vidal, A. Rener, F. Mut. Asociacion
Espanola, Nuclear Medicine, Montevideo, Uruguay
Objective: To investigate if myocardial stunning during a diagnostic stress test, defined
as a transient ischemic dysfunction of the left ventricle, has prognostic value in patients
with known or suspected coronary artery disease (CAD). Methods: A population of 128
patients (pts.) was analyzed (76% men), ages 6111 years, which were submitted for
stress myocardial perfusion studies with 99mTc sestamibi. Fifty pts. had previous
myocardial infarction (MI). Stress test was exercise in 94 cases and dipyridamole in 34.
A gated SPECT study was performed both in the rest and post-stress periods using a
two-day protocol, and left ventricular ejection fraction (LVEF) was calculated for each
situation using QGS software. A decrease of at least 10% in post-stress LVEF with
respect to the basal (rest) value was considered positive criteria for diagnosis of
myocardial stunning. Additional variables included the presence of reversible perfusion
defects, a rest LVEF value 40% and ECG changes with ST 1.5 mm. Hard (death,
MI) and soft (unstable angina, revascularization, cardiac failure, arrhythmia) cardiac
events were recorded over a follow-up period of 742.7 months. Chi-square test was
applied for statistical analysis. Results: Stunning was observed in 24% of cases, basal
FEVI 40% in 22%, ischemic perfusion pattern (reversible defects) in 52% and ST 1.5
mm in 30%. Thirty-five percent of pts. who exercised and 33% of those receiving
dipyridamole demonstrated stunning (pns). Thirty hard events (26 deaths) and 38 soft
events were registered. Myocardial stunning was predictive of total cardiac events
(p0.007) and hard events (p0.02) but not of soft events (pns). Basal LVEF40%
was predictive of total events (p0.0005) and both hard and soft events separately
(p0.025 and 0.045respectively) while reversible defects and ST 1.5 mm were
predictive of total events but not of hard or soft events separately (pns). Conclusion:
Myocardial stunning defined as a negative variation of 10% in post-stress LVEF
compared with basal LVEF determined by GSPECT can be observed during both
exercise or dipyridamole stress tests, and represents a variable of prognostic value in
pts. with known or suspected CAD.
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